Dementia, including avohilmo

F5_DEMENTIA_INCLAVO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — F00-F09 1 out of 7 registries used, show all original rules.	10401
4. Check minimum number of events None	10401
5. Include endpoints F5_DEMENTIA	27454
6. Filter based on genotype QC (FinnGen only)	27454

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_DEMENTIA_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_DEMENTIA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	F0[0-3]
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dementia, including avohilmo based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	426237	260291	161598
Only index persons	319065	198585	120480
Unadjusted period prevalence (%)
Whole population	6.31	7.46	4.52
Only index persons	6.28	7.30	4.60
Median age at first event (years)
Whole population	80.83	81.81	79.31
Only index persons	81.04	82.03	79.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	27454	12583	14871
Unadjusted period prevalence (%)	5.52	4.29	6.56
Median age at first event (years)	78.96	79.37	78.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8199: Matched controls
73416

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

+∞

323.0

482

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

323.0

946

G30.0

ICD-10 Finland

Alzheimer disease with early onset

279.1

323.0

468

G30.1

ICD-10 Finland

Alzheimer disease with late onset

116.5

323.0

2278

242

SPAT1216

SPAT

Assessment of functional ability

3.7

323.0

2539

7967

G30.8

ICD-10 Finland

Other Alzheimer disease

116.5

323.0

659

N06DA03

ATC

rivastigmine; oral, transdermal

364.8

323.0

1903

P20

ICPC

Memory disturbance

13.0

323.0

4071

5175

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

5.6

323.0

1421

2641

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

9.8

323.0

2432

3036

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

145.5

323.0

924

N06DA04

ATC

galantamine; oral

390.0

323.0

829

G30

ICD-10 Finland

Alzheimer disease

120.6

323.0

373

P70

ICPC

Dementia

66.2

323.0

630

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

+∞

323.0

701

F06.7

ICD-10 Finland

Mild cognitive disorder

12.7

323.0

816

634

F03

ICD-10 Finland

Unspecified dementia

+∞

323.0

1959

N06DA02

ATC

donepezil; oral

343.2

323.0

3148

133

N05AH04

ATC

quetiapine; oral

4.8

323.0

1898

4363

SPAT1245

SPAT

Provision of support and information to patient’s family members

9.1

323.0

1056

1174

N06DX01

ATC

memantine; oral

599.7

323.0

3073

SPAT1053

SPAT

Memory test

5.9

323.0

3799

9412

N05AX08

ATC

risperidone; systemic

10.6

323.0

1491

1501

A28

ICPC

Limited function/disability NOS

4.2

323.0

2531

7081

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

+∞

323.0

1184

SPAT1234

SPAT

Support of social functional capacity

6.3

322.4

941

1474

F01.9

ICD-10 Finland

Vascular dementia, unspecified

+∞

314.7

313

TAB00

NOMESCO Finland

Lumbar puncture

7.3

314.0

825

1114

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

5.7

308.9

986

1726

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.1

307.0

2112

7428

AA1AD

NOMESCO Finland

CT of head and brain

2.6

302.8

3051

13597

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

+∞

279.2

278

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

272.2

271

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

271.2

270

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

6.3

262.0

757

1158

R41.3

ICD-10 Finland

Other amnesia

7.3

258.4

672

886

R53

ICD-10 Finland

Malaise and fatigue

2.7

252.9

2172

8639

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

241.0

2044

8034

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

+∞

240.9

240

XA800

NOMESCO Finland

Neuropsychological investigation

6.4

232.1

667

1008

SPAT1254

SPAT

Administration of medicine

2.8

223.6

1742

6462

L28

ICPC

Limited function/disability (L)

2.6

217.2

1970

7978

N03AG01

ATC

valproic acid; systemic, rectal

5.0

216.1

759

1459

G20

ICD-10 Finland

Parkinson disease

5.6

211.2

670

1144

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

206.0

2973

15134

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

5.9

202.4

618

1005

R41.0

ICD-10 Finland

Disorientation, unspecified

6.9

200.6

539

739

N06AX11

ATC

mirtazapine; oral

2.1

183.5

2837

14695

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

181.8

1054

3160

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

+∞

170.3

170

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

+∞

166.3

166

N05AH03

ATC

olanzapine; systemic

4.7

164.2

609

1230

N87

ICPC

Parkinsonism

8.9

161.2

366

384

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

147.9

1371

5474

N05BA04

ATC

oxazepam; oral

2.1

147.8

2177

10834

SPAT1229

SPAT

Assessment of need for aid

2.8

143.0

1044

3625

N06AB10

ATC

escitalopram; oral

2.4

142.6

1426

5917

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

11.8

141.7

276

216

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.0

140.6

913

2936

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.3

138.8

777

2245

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.0

132.3

462

871

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

127.1

127

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.6

123.4

605

1572

F05.9

ICD-10 Finland

Delirium, unspecified

7.0

123.3

325

430

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

+∞

123.1

123

N06AX26

ATC

vortioxetine; oral

4.4

121.9

477

1011

A04

ICPC

Weakness/tiredness general

2.3

120.2

1253

5262

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

118.1

118

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

116.5

892

3165

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

115.4

1749

8664

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.0

115.1

736

2328

A06AD11

ATC

lactulose; oral

2.2

114.9

1416

6424

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

35.8

114.0

153

F05.1

ICD-10 Finland

Delirium superimposed on dementia

115.4

112.9

127

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

7.5

112.8

283

348

SPAT1301

SPAT

No procedures

1.8

111.8

3081

18772

SPAT1172

SPAT

Guidance concerning hydration

5.4

110.6

354

603

N04BD01

ATC

selegiline; oral

6.7

108.7

296

410

WYA20

NOMESCO Finland

Home visit

10.0

108.3

229

211

F00

ICD-10 Finland

Dementia in Alzheimer disease

+∞

108.0

108

G31.0

ICD-10 Finland

Circumscribed brain atrophy

20.9

107.8

167

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.0

107.7

685

2155

SPAT1101

SPAT

Orthostatic test

3.2

107.1

622

1836

SPAT1304

SPAT

Counselling and guidance related to ageing

2.5

106.1

920

3495

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

+∞

105.0

105

F01

ICD-10 Finland

Vascular dementia

+∞

104.0

104

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

9.4

103.0

225

220

N05BA06

ATC

lorazepam; systemic, sublingual

3.3

103.0

580

1673

N06AB04

ATC

citalopram; systemic

1.9

102.8

1771

9158

F01.2

ICD-10 Finland

Subcortical vascular dementia

+∞

101.0

101

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.4

100.7

394

833

109

Kela drug reimbursment

Multiple sclerosis

16.1

99.1

168

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

98.9

1336

6263

G35

ICD-10 Finland

Multiple sclerosis

9.0

96.9

216

219

SPAT1360

SPAT

Extensive global examination

2.4

95.3

875

3418

U04

ICPC

Incontinence urine

3.1

94.0

582

1790

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

+∞

93.0

SPAT1252

SPAT

Overall medication plan or its review

2.5

92.9

824

3155

N05AD01

ATC

haloperidol; systemic

4.7

92.4

338

667

G04BD12

ATC

mirabegron; oral

2.0

89.3

1253

5945

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

88.2

1231

5823

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

86.0

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

18.7

84.9

136

A29

ICPC

General symptom/complaint other

2.1

84.8

1100

5042

I95.1

ICD-10 Finland

Orthostatic hypotension

3.5

84.8

438

1180

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.2

84.3

485

1417

S06.0

ICD-10 Finland

Concussion

2.3

84.2

874

3620

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

83.5

2048

11793

S01.0

ICD-10 Finland

Open wound of scalp

2.5

83.2

736

2808

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

82.3

773

3041

N04BD02

ATC

rasagiline; oral

8.5

82.0

189

203

R42

ICD-10 Finland

Dizziness and giddiness

1.7

77.5

2028

11862

S72.0

ICD-10 Finland

Fracture of neck of femur

3.4

73.7

380

1021

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.2

73.0

295

642

R55

ICD-10 Finland

Syncope and collapse

2.0

72.6

1088

5262

N03AE01

ATC

clonazepam; systemic

2.6

72.6

590

2144

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

6.1

72.4

209

313

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

72.1

997

4669

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.2

71.4

288

626

SPAT1167

SPAT

Insertion of urinary catheter

3.1

71.1

422

1258

AXX01

SPAT

5.1

70.9

236

420

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.7

70.0

252

489

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.6

68.9

255

509

W19

ICD-10 Finland

Unspecified fall

2.1

68.4

830

3673

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

68.0

1190

6081

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

67.0

555

2034

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

66.3

2822

18584

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

66.3

703

2924

193

Kela drug reimbursment

Rasagiline

8.0

65.1

155

176

N06AX16

ATC

venlafaxine; oral

2.0

64.7

896

4188

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

4.9

64.4

223

415

N02BE01

ATC

paracetamol; systemic, rectal

1.7

64.0

7098

57933

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

63.8

548

2049

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

62.5

726

3146

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

17.8

61.5

100

N29

ICPC

Neurological sympt/complt other

4.1

61.5

257

578

N04BC04

ATC

ropinirole; oral

5.2

59.7

196

344

SPAT1139

SPAT

Nutrition survey

3.2

58.9

341

997

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

58.6

894

4330

L03AB07

ATC

interferon beta-1a; parenteral

20.3

58.1

F21

ICPC

8.9

57.6

128

130

N03AX14

ATC

levetiracetam; systemic

3.5

57.1

286

751

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.2

56.6

231

508

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.2

56.1

228

500

SPAT1263

SPAT

Sampling

1.5

55.7

3516

24929

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

54.4

1343

7608

N06AB06

ATC

sertraline; oral

2.1

54.3

709

3225

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

8.0

54.2

129

147

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

53.7

793

3785

N86

ICPC

Multiple sclerosis

10.6

53.5

108

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.5

51.9

193

388

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

51.7

2621

17682

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

51.4

281

789

P29

ICPC

Psychological sympt/compl other

3.0

51.3

317

970

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

51.0

1327

7615

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

+∞

50.9

N05AA02

ATC

levomepromazine; systemic

2.8

50.9

354

1169

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.8

50.6

341

1105

N03AX09

ATC

lamotrigine; oral

3.2

50.3

285

821

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

50.3

429

1593

F02.89

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without information of additional symptoms

+∞

49.9

N99

ICPC

Neurological disease other

5.1

49.3

165

297

N06AX21

ATC

duloxetine; oral

1.9

49.1

749

3616

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

48.9

2593

17611

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

48.2

1653

20217

N30.0

ICD-10 Finland

Acute cystitis

1.7

48.1

1084

5960

N03AF02

ATC

oxcarbazepine; oral

3.0

47.9

290

873

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

47.5

983

5266

N04BX02

ATC

entacapone; oral

13.5

47.2

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

47.0

862

4437

N04AA02

ATC

biperiden; systemic

4.0

46.5

195

441

L03AX13

ATC

glatiramer acetate; parenteral

21.1

45.8

SPAT1262

SPAT

Handing over of treatment supplies

1.5

44.7

1723

10881

F05.8

ICD-10 Finland

Other delirium

7.3

44.7

112

139

N27

ICPC

Fear of neurological disease other

3.9

44.5

191

441

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

+∞

43.9

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

+∞

43.9

N28

ICPC

Limited function/disability (N)

3.8

43.8

195

465

SPAT1050

SPAT

Extensive neurological examination

3.2

43.3

246

710

C03CA01

ATC

furosemide; systemic

1.4

42.8

2450

16789

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

41.8

465

1966

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

4.5

41.8

154

308

N04BC05

ATC

pramipexole; oral

1.9

41.0

681

3382

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

33.0

40.8

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.9

40.7

175

405

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

40.5

607

2901

F0019, G301

ICD-10 Finland

+∞

39.9

N05AB03

ATC

perphenazine; systemic, rectal

2.7

39.9

286

962

N05AH02

ATC

clozapine; systemic

5.5

39.8

124

206

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

39.6

373

1459

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.0

39.4

132

239

C10AA01

ATC

simvastatin; oral

1.4

38.5

4258

32516

N19

ICPC

Speech disorder

4.1

38.5

158

351

E86

ICD-10 Finland

Volume depletion

3.2

38.0

215

619

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

+∞

37.9

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

37.7

398

1645

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

37.6

1313

8063

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

13.8

37.2

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

37.2

219

649

R32

ICD-10 Finland

Unspecified urinary incontinence

2.6

37.2

280

969

F009, G309

ICD-10 Finland

+∞

37.0

N05BA01

ATC

diazepam; systemic, rectal

1.6

36.5

1014

5879

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

+∞

36.0

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

35.9

898

5061

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

13.4

35.7

130

Kela drug reimbursment

Malignant tumour

0.5

35.7

260

4702

N05AX12

ATC

aripiprazole; systemic

3.5

35.6

176

459

F22.0

ICD-10 Finland

Delusional disorder

4.0

35.4

147

331

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

35.0

1021

5992

K90

ICPC

Stroke/cerebrovascular accident

2.5

35.0

294

1085

F001, G301

ICD-10 Finland

+∞

35.0

R1250

NOMESCO Finland

Evaluation of functional capability

3.2

34.9

197

566

N02AA05

ATC

oxycodone; systemic

1.5

34.8

1228

7543

Z75.5

ICD-10 Finland

Holiday relief care

10.2

34.7

G40

ICD-10 Finland

Epilepsy

5.3

34.7

111

191

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

34.4

561

2761

G72.8

ICD-10 Finland

Other specified myopathies

3.7

34.4

157

384

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

34.3

751

4069

H02AB02

ATC

dexamethasone; systemic

0.5

34.3

313

5284

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

34.1

299

1127

N04BB01

ATC

amantadine; oral

3.4

34.0

171

453

S70.0

ICD-10 Finland

Contusion of hip

2.4

33.8

291

1087

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.8

33.6

150

360

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.6

33.2

155

387

N05AN01

ATC

lithium; oral

3.3

33.1

177

491

R35

ICD-10 Finland

Polyuria

1.8

33.1

596

3037

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

+∞

33.0

N17

ICPC

Vertigo/dizziness

1.6

32.9

959

5620

R33

ICD-10 Finland

Retention of urine

1.7

32.8

709

3825

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

32.6

185

535

P03

ICPC

Feeling depressed

2.1

32.5

414

1853

R11

ICD-10 Finland

Nausea and vomiting

1.8

32.5

575

2911

SPAT1260

SPAT

Consultation of another employee

1.5

32.4

1518

9901

R44.1

ICD-10 Finland

Visual hallucinations

8.7

31.8

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

31.7

633

3333

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.9

31.6

107

197

N03AX18

ATC

lacosamide; systemic

7.1

31.6

102

A01

ICPC

Pain general/multiple sites

1.8

31.4

600

3114

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.8

30.8

138

333

N05CD07

ATC

temazepam; oral

1.6

30.5

994

5981

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

30.4

564

2899

M03BX01

ATC

baclofen; systemic

3.3

30.3

161

445

N04BC09

ATC

rotigotine; transdermal

6.9

30.3

102

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

30.3

263

988

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.4

30.2

156

422

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

30.2

321

1330

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.5

30.1

146

376

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.4

30.1

155

419

F01.0

ICD-10 Finland

Vascular dementia of acute onset

+∞

30.0

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

+∞

30.0

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

+∞

30.0

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

+∞

30.0

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.2

29.9

165

469

G04BD08

ATC

solifenacin; oral

1.7

29.9

630

3367

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.9

29.9

127

293

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.3

29.8

156

427

Z29

ICPC

Social problem NOS

3.7

29.4

134

328

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

29.3

470

2299

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.8

28.7

190

609

N03AF01

ATC

carbamazepine; oral, rectal

2.0

28.7

402

1870

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.1

28.6

329

1412

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

28.6

230

828

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.6

28.5

210

721

R63.4

ICD-10 Finland

Abnormal weight loss

2.1

28.5

335

1451

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

5.1

28.5

165

183

Kela drug reimbursment

Lamotrigin and topiramate

5.8

28.4

129

SPAT1240

SPAT

Therapeutic discussion

1.8

28.3

531

2737

SPAT1125

SPAT

Stoma care and guidance

2.9

28.1

174

536

L03AB08

ATC

interferon beta-1b; parenteral

17.6

28.1

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

28.0

698

3915

F0009, G300

ICD-10 Finland

+∞

28.0

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

+∞

28.0

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

27.9

396

1852

K59.0

ICD-10 Finland

Constipation

1.9

27.9

454

2231

J01EA01

ATC

trimethoprim; systemic

1.4

27.8

1730

11855

K91

ICPC

Cerebrovascular disease

3.1

27.6

158

462

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

27.5

390

1823

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

27.4

3125

23508

A27

ICPC

Fear of other disease NOS

2.0

27.3

378

1750

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

27.2

528

2754

SPAT1281

SPAT

Other administrative function

1.7

27.0

640

3540

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

+∞

27.0

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

+∞

27.0

164

Kela drug reimbursment

Fingolimod

26.3

26.9

J01CA08

ATC

pivmecillinam; oral

1.3

26.8

2436

17722

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

26.8

456

2277

S06.3

ICD-10 Finland

Focal brain injury

3.6

26.5

124

311

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.6

26.3

184

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.7

26.2

117

283

A04AA02

ATC

granisetron; systemic, transdermal

0.5

26.1

156

3021

F02.89*E03.9

ICD-10 Finland

Dementia in hypothyroidism, acquired

+∞

26.0

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

26.0

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

+∞

26.0

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

+∞

26.0

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.9

25.8

113

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

25.6

167

532

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.8

25.4

115

A10AE04

ATC

insulin glargine; parenteral

1.6

25.3

733

4276

P99

ICPC

Psychological disorders other

3.1

25.2

145

426

R44.3

ICD-10 Finland

Hallucinations, unspecified

8.7

24.9

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

24.9

1643

11341

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

24.8

723

9287

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

24.5

1899

13447

353

Kela drug reimbursment

Cladribine and fingolimod

27.8

24.4

S00.0

ICD-10 Finland

Superficial injury of scalp

2.7

24.4

169

559

R1250

SPAT

5.7

24.4

114

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

24.4

588

3266

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

5.8

24.3

111

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

24.1

231

914

F06.0

ICD-10 Finland

Organic hallucinosis

14.7

24.0

H46

ICD-10 Finland

Optic neuritis

5.5

23.9

117

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

23.9

2165

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.1

23.7

213

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.5

23.6

186

664

P15

ICPC

Chronic alcohol abuse

2.7

23.6

169

572

F10.24

ICD-10 Finland

Alcohol depence active use

3.6

23.6

109

272

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

7.3

23.5

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

10.3

23.5

N06AX12

ATC

bupropion; oral

2.3

23.4

222

874

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

23.4

1983

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

23.4

323

1495

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

23.4

588

3304

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6.8

23.4

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.8

23.4

101

238

S22.3

ICD-10 Finland

Fracture of rib

1.7

23.3

489

2608

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

23.2

352

1691

Z28

ICPC

Limited function/disability (Z)

6.9

23.1

K08.3

ICD-10 Finland

Retained dental root

1.7

22.9

535

2945

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

22.9

431

2223

N03AB02

ATC

phenytoin; systemic

3.5

22.9

109

279

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

22.8

285

1270

N18

ICPC

Paralysis/weakness

2.5

22.7

180

644

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.0

22.7

137

417

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

22.5

221

885

N88

ICPC

Epilepsy

5.5

22.5

111

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.3

22.5

118

326

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

22.2

1255

8416

B01AC04

ATC

clopidogrel; oral

1.4

22.2

1430

9810

N05CF01

ATC

zopiclone; oral

1.3

22.1

2368

17519

N05AF03

ATC

chlorprothixene; systemic

2.6

21.9

168

591

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.8

21.9

147

480

SPAT1284

SPAT

Extensive health certificate

2.4

21.8

196

751

SPAT1310

SPAT

Counselling related to known health issue

1.3

21.7

2566

19223

F32

ICD-10 Finland

Depressive episode

2.1

21.7

263

1158

SPAT1127

SPAT

Enema

4.2

21.6

180

SPAT1138

SPAT

Guidance concerning bowel function

2.9

21.4

131

403

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.4

21.2

163

H02AA02

ATC

fludrocortisone; oral

4.5

21.2

151

P05

ICPC

Senility, feeling/behaving old

6.8

21.1

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

8.5

21.1

G04BD07

ATC

tolterodine; oral

1.8

21.0

403

2092

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

+∞

21.0

F00, F03

ICD-10 Finland

+∞

21.0

EBA30

NOMESCO Finland

Excision of root of tooth

1.7

20.8

416

2188

N05BE01

ATC

buspirone; oral

2.3

20.8

195

763

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.5

20.8

150

Y94.0

ICD-10 Finland

Accident at home

2.6

20.7

151

518

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

20.6

1289

8782

P76

ICPC

Depressive disorder

2.0

20.5

267

1209

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

20.4

281

1298

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.7

20.4

217

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

20.3

244

1071

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.4

20.3

101

269

D21

ICPC

Swallowing problem

2.8

20.2

136

444

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

20.2

1947

14163

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.2

20.1

109

309

L01BC06

ATC

capecitabine; oral

0.4

20.1

1756

N07BB01

ATC

disulfiram; oral

2.1

20.0

237

1033

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

+∞

20.0

F0011, G301

ICD-10 Finland

+∞

20.0

F0014, G301

ICD-10 Finland

+∞

20.0

AA1AA

NOMESCO Finland

Head X-ray examination

3.6

19.9

235

G04BD09

ATC

trospium; oral

2.1

19.9

232

1006

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

25.1

19.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

19.7

1226

8341

G91.0

ICD-10 Finland

Communicating hydrocephalus

5.1

19.7

111

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.5

19.6

139

SPAT1236

SPAT

Informing family of child’s disability

2.3

19.5

189

753

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.4

19.4

148

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.0

19.4

257

1173

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.9

19.4

118

362

L04AA31

ATC

teriflunomide; oral

26.9

19.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.9

19.3

192

L04AA27

ATC

fingolimod; oral

22.8

19.2

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.8

19.1

198

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.5

19.1

230

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

12.1

19.0

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

+∞

19.0

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.1

18.9

169

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

6.3

18.9

XF606

NOMESCO Finland

Ortostatic test

3.5

18.9

232

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.0

18.9

111

334

WX402

NOMESCO Finland

General anaesthesia

0.7

18.9

635

7973

UKC02

NOMESCO Finland

Cystoscopy

1.3

18.8

1405

9834

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.3

18.8

185

743

R60.0

ICD-10 Finland

Localized oedema

1.4

18.8

881

5695

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

18.7

1776

12877

N05AD03

ATC

melperone; systemic

3.7

18.6

198

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.4

18.6

244

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

4.0

18.4

169

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

18.3

1560

11130

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2.7

18.3

128

428

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.9

18.2

115

361

L57.0

ICD-10 Finland

Actinic keratosis

0.7

18.1

478

6282

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

18.1

238

1083

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

18.1

435

2413

P28

ICPC

Limited function/disability (P)

4.5

18.1

130

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.0

18.1

109

332

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.2

18.1

192

799

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.1

18.1

155

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

18.0

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.6

17.9

485

2781

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

16.3

17.9

AA1AD

SPAT

9.0

17.8

R13

ICD-10 Finland

Dysphagia

1.6

17.8

495

2856

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.6

17.7

207

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

10.9

17.7

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

17.6

360

1906

N05AC02

ATC

thioridazine; oral

2.5

17.6

138

494

N06AB03

ATC

fluoxetine; oral

1.4

17.5

795

5107

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

9.5

17.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

17.3

201

870

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.9

17.3

162

C10AA05

ATC

atorvastatin; oral

1.2

17.2

3484

27573

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.1

17.0

277

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

+∞

17.0

F01.8

ICD-10 Finland

Other vascular dementia

+∞

17.0

N06AA09

ATC

amitriptyline; systemic

1.4

17.0

738

4700

W06

ICD-10 Finland

Fall involving bed

3.9

16.9

165

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.0

16.8

153

AA1CG

SPAT

4.7

16.8

112

SPAT1251

SPAT

Organisation of medication

1.9

16.7

258

1249

S97

ICPC

Chronic ulcer skin

1.6

16.6

444

2535

S06.2

ICD-10 Finland

Diffuse brain injury

3.5

16.6

200

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.5

16.5

130

468

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

16.5

942

10908

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

16.4

337

1788

F34.1

ICD-10 Finland

Dysthymia

2.1

16.4

182

773

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

16.3

1727

18506

N80

ICPC

Head injury other

2.5

16.3

127

454

OAB43

SPAT

0.4

16.2

1372

2AB04

NOMESCO Finland

10.7

16.0

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.7

16.0

174

F01.1

ICD-10 Finland

Multi-infarct dementia

+∞

16.0

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

+∞

16.0

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

+∞

16.0

SPAT1285

SPAT

Provision of consultation response

1.6

15.9

422

2401

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

15.8

735

4741

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

15.8

730

8721

Q90.9

ICD-10 Finland

Down syndrome, unspecified

152.4

15.8

N05AF05

ATC

zuclopenthixol; systemic

3.4

15.7

200

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.3

15.6

210

Z03

ICPC

Housing/neighbourhood problem

4.7

15.6

101

R51.80

ICD-10 Finland

Headache

1.4

15.5

795

5218

N06AX03

ATC

mianserin; oral

1.7

15.5

338

1826

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.2

15.5

231

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

5.3

15.5

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

15.4

107

358

A10BB12

ATC

glimepiride; oral

1.5

15.4

577

3564

L75

ICPC

Fracture: femur

2.7

15.4

103

338

WX212

NOMESCO Finland

Femoral plexus blockade

2.2

15.4

151

610

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

15.3

214

998

Z11

ICPC

Compliance/being ill problem

4.4

15.3

115

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

15.3

709

4569

S09.9

ICD-10 Finland

Unspecified injury of head

3.0

15.3

278

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

10.4

15.3

N05BA09

ATC

clobazam; oral

5.5

15.3

A10AE05

ATC

insulin detemir; parenteral

1.6

15.2

373

2083

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

15.2

528

3211

A10BB01

ATC

glibenclamide; oral

1.8

15.1

274

1401

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.8

15.1

322

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

15.1

334

1815

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

15.0

411

2360

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.6

15.0

112

392

F0232, G20

ICD-10 Finland

+∞

15.0

F02

ICD-10 Finland

Dementia in other diseases classified elsewhere

+∞

15.0

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.3

14.9

114

R47.0

ICD-10 Finland

Dysphasia and aphasia

3.1

14.9

251

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.1

14.9

174

759

EBA00

NOMESCO Finland

Extraction of tooth

1.2

14.9

2171

16515

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

7.2

14.8

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

6.4

14.8

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.5

14.8

177

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

14.7

2023

15282

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

6.6

14.7

E87.6

ICD-10 Finland

Hypokalaemia

1.9

14.7

231

1127

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

14.7

727

4744

R5110

SPAT

1.9

14.6

211

999

P01

ICPC

Feeling anxious/nervous/tense

1.7

14.6

328

1789

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

14.6

1526

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.3

14.5

203

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.2

14.5

144

583

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

14.4

934

6375

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.1

14.4

234

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.6

14.4

B01AA03

ATC

warfarin; systemic

1.3

14.3

1602

11803

G40.89

ICD-10 Finland

Other epilepsy

5.0

14.3

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.0

14.2

245

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.9

14.2

137

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

14.1

1776

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

14.1

161

696

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

14.0

448

2671

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

+∞

14.0

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

14.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

13.9

3452

27668

Z60.8

ICD-10 Finland

Other problems related to social environment

9.7

13.8

I95.9

ICD-10 Finland

Hypotension, unspecified

2.4

13.8

115

430

L76

ICPC

Fracture: other

1.9

13.7

201

956

IGP01

NOMESCO Finland

Psychiatric family contact

8.0

13.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

13.7

2566

20011

N03AX11

ATC

topiramate; oral

2.6

13.6

101

355

T08

ICPC

Weight loss

2.4

13.6

116

438

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

13.5

2114

16175

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

13.5

209

1016

M01AH05

ATC

etoricoxib; oral

0.8

13.4

3259

32368

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

13.4

326

1818

R2110

NOMESCO Finland

Giving the first information

1.6

13.4

393

2295

Z72.1

ICD-10 Finland

Alcohol use

2.9

13.3

262

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.7

13.3

290

1568

D12

ICPC

Constipation

1.7

13.3

259

1358

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

5.2

13.3

SPAT1014

SPAT

Treatment of eyes

2.2

13.2

128

514

A86

ICD-10 Finland

Unspecified viral encephalitis

4.6

13.2

P72

ICPC

Schizophrenia

2.7

13.1

302

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.9

13.1

255

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

13.1

352

2015

S20

ICPC

Corn/callosity

2.0

13.0

171

783

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

13.0

160

714

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.5

13.0

158

F01.84

ICD-10 Finland

Other specified vascular dementia other mixed symptoms of mixed type

+∞

13.0

4378X

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]

+∞

13.0

F01.33

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression

+∞

13.0

E0000UV

ATC

1.2

13.0

2619

20545

SPAT1255

SPAT

Intravenous administration of medicine

1.5

12.9

479

2951

SPAT1244

SPAT

Occupational therapy

2.7

12.9

294

U28

ICPC

Limited function/disability (U)

2.6

12.8

316

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.5

12.8

1575

Z08

ICPC

Social welfare problem

3.1

12.8

208

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

2.3

12.8

117

457

U13

ICPC

Bladder symptom/complaint other

1.8

12.8

224

1137

R4130

NOMESCO Finland

Speech therapy

2.0

12.8

162

730

A05

ICPC

Feeling ill

1.7

12.8

276

1489

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.6

12.8

142

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

4.1

12.7

107

L04AX07

ATC

dimethyl fumarate; oral

13.2

12.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

12.6

2096

16111

XF606

SPAT

6.1

12.6

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

23.1

12.6

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

12.6

150

662

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.0

12.6

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.0

12.5

221

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.8

12.5

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.2

12.5

182

-1

ICPC

2.1

12.5

140

599

Z50.1

ICD-10 Finland

Other physical therapy

1.5

12.5

386

2282

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

12.5

689

4577

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

12.5

430

2610

SPAT1104

SPAT

Monitoring of emergency patient

1.5

12.3

497

3118

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.4

12.3

108

414

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.2

12.3

175

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

12.3

564

3629

C09AA05

ATC

ramipril; oral

1.2

12.2

2070

15941

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

4.3

12.1

S20.2

ICD-10 Finland

Contusion of thorax

1.6

12.1

288

1599

A10BA02

ATC

metformin; oral

1.2

12.1

2225

17270

HA1RA

SPAT

0.3

12.0

696

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.4

12.0

357

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.4

12.0

357

N04BC02

ATC

pergolide; oral

11.6

12.0

G04CA02

ATC

tamsulosin; oral

1.2

12.0

1941

14870

N06AB05

ATC

paroxetine; oral

1.6

12.0

325

1865

F02.8

ICD-10 Finland

Dementia in other specified diseases classified elsewhere

+∞

12.0

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

12.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

12.0

1232

8966

Z51.88

ICD-10 Finland

Other specified medical care

2.0

11.9

152

689

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.4

11.9

155

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.3

11.9

108

421

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

11.9

1731

13112

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.1

11.9

185

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.8

11.8

967

10733

P18

ICPC

Medication abuse

6.3

11.8

S01.8

ICD-10 Finland

Open wound of other parts of head

2.5

11.7

340

C01DA14

ATC

isosorbide mononitrate; oral

1.3

11.7

1156

8372

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

11.7

531

3411

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

11.6

532

3422

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

11.6

193

963

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

11.6

347

E16.19

ICD-10 Finland

Other specified hypoglycaemia

5.2

11.5

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

11.5

817

5649

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

7.0

11.5

N06BA07

ATC

modafinil; oral

8.3

11.5

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.4

11.5

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

11.5

135

594

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.7

11.4

123

C07AB02

ATC

metoprolol; systemic

1.2

11.4

1590

11976

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

3.3

11.4

156

F61.0

ICD-10 Finland

Mixed personality disorders

2.8

11.4

225

N05AL01

ATC

sulpiride; systemic

2.3

11.3

107

426

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

11.3

623

4135

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

3.8

11.3

115

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

11.3

265

1465

N07XX09

ATC

[U] dimethyl fumarate; oral

16.1

11.3

S28

ICPC

Limited function/disability (S)

3.5

11.3

134

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.7

11.2

N05BA02

ATC

chlordiazepoxide; systemic

1.9

11.2

160

757

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.7

11.2

256

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

11.1

735

5028

G04BD11

ATC

fesoterodine; oral

1.7

11.1

240

1297

R45.1

ICD-10 Finland

Restlessness and agitation

9.9

11.1

N03AX12

ATC

gabapentin; oral

1.3

11.1

1052

7571

A46

ICD-10 Finland

Erysipelas

1.3

11.1

1029

7382

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.9

11.1

104

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.5

11.1

1411

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.1

11.0

127

553

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

8.3

11.0

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

7.7

11.0

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

3.0

11.0

189

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.2

11.0

108

440

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

+∞

11.0

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

+∞

11.0

F01.14

ICD-10 Finland

Multi-infarct dementia's other mixed symptoms of mixed type

+∞

11.0

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

11.0

F0004, G300

ICD-10 Finland

+∞

11.0

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

+∞

11.0

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

11.0

F02.84

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type

+∞

11.0

N06AA12

ATC

doxepin; systemic

1.5

11.0

368

2223

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

5.7

11.0

K92.0

ICD-10 Finland

Haematemesis

1.9

11.0

155

733

S80.0

ICD-10 Finland

Contusion of knee

1.5

11.0

335

1980

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

11.0

458

2895

T90

ICPC

Diabetes non-insulin dependent

1.2

11.0

1923

14831

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

10.5

11.0

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

10.9

644

4327

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

10.8

622

4159

N06AX05

ATC

trazodone; oral

2.0

10.8

137

622

S01

ICD-10 Finland

Open wound of head

2.5

10.8

305

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.1

10.8

121

522

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

4.8

10.8

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

7.5

10.8

N05BA12

ATC

alprazolam; oral

1.4

10.8

612

4086

R40.2

ICD-10 Finland

Coma, unspecified

2.9

10.8

193

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

10.7

277

M54.5

ICD-10 Finland

Low back pain

1.2

10.7

2048

15919

F31

ICD-10 Finland

Bipolar affective disorder

3.2

10.7

159

F32.8

ICD-10 Finland

Other depressive episodes

2.9

10.7

207

XA400

NOMESCO Finland

EEG

3.5

10.7

126

K03.66

ICD-10 Finland

Tooth plaque

1.5

10.7

408

2535

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

9.9

10.7

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

4.9

10.7

359

Kela drug reimbursment

Mirabegroni

2.9

10.6

190

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

7.7

10.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

10.5

738

5092

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

4.3

10.5

4AA23

NOMESCO Finland

22.4

10.5

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.7

10.5

110

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.9

10.4

142

663

U07

ICPC

Urine symptom/complaint other

1.4

10.4

425

2677

H04AA01

ATC

glucagon; nasal, parenteral

2.4

10.3

340

XKD00

NOMESCO Finland

Uroflowmetry

1.2

10.3

1419

10664

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

5.7

10.3

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.0

10.3

178

R1260

NOMESCO Finland

Evaluation of communicative skills

2.0

10.3

124

553

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

10.2

172

2480

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

10.2

170

851

NG1AA

SPAT

0.3

10.2

762

A04AA01

ATC

ondansetron; systemic, rectal

0.6

10.2

227

3083

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.2

10.2

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

10.1

191

994

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.3

10.1

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.4

10.1

N04BC06

ATC

cabergoline; oral (dopamine agonists)

4.4

10.1

IHZ08

SPAT

25.1

10.1

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

4.8

10.1

Y07

ICD-10 Finland

Other maltreatment

4.5

10.1

RT150

NOMESCO Finland

8.2

10.1

R4120

NOMESCO Finland

Occupational therapy

1.5

10.1

399

2493

F06.32

ICD-10 Finland

Organic depression

6.1

10.1

N06AA06

ATC

trimipramine; systemic

1.8

10.1

159

779

S22

ICPC

Nail symptom/complaint

1.4

10.1

411

2587

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.8

10.0

202

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

10.0

214

1156

F02.04

ICD-10 Finland

Dementia in Pick's disease other additional symptoms of mixed type

+∞

10.0

F02.82

ICD-10 Finland

Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations

+∞

10.0

F0200, G310

ICD-10 Finland

+∞

10.0

F0203, G310

ICD-10 Finland

+∞

10.0

F0029, G308

ICD-10 Finland

+∞

10.0

F01.89

ICD-10 Finland

Other specified vascular dementia without information on additional symptoms

+∞

10.0

F01.13

ICD-10 Finland

The other additional symptoms of multi-infarct dementia, mainly depression

+∞

10.0

F01.22

ICD-10 Finland

Subcortical vascular dementia with additional symptoms, mainly hallucinations

+∞

10.0

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

3.8

9.9

U29

ICPC

Urinary symptom/complaint other

1.7

9.9

192

1011

E000001

ATC

1.2

9.8

1195

8858

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.5

9.8

266

LAITO

NOMESCO Finland

29.1

9.8

SPAT1232

SPAT

Communication with help of interpreter or assistant

5.8

9.8

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

5.1

9.8

A04AA55

ATC

palonosetron, combinations; systemic

0.4

9.7

828

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

3.7

9.7

J01MA02

ATC

ciprofloxacin; systemic

1.2

9.7

2816

22663

D17

ICPC

Incontinence of bowel

2.6

9.7

254

T05

ICPC

Feeding problem of adult

3.4

9.6

123

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.2

9.6

138

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

9.6

886

6354

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.1

9.5

111

486

G41.0

ICD-10 Finland

Grand mal status epilepticus

6.5

9.5

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

9.5

951

J01DB01

ATC

cefalexin; oral

1.2

9.5

6021

51451

NF3AA

NOMESCO Finland

Femur X-ray examination

2.0

9.5

126

581

A10AA02

ATC

1.8

9.5

152

751

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

9.5

190

1008

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

9.5

138

659

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

9.5

617

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.9

9.4

138

661

Z75.0

ICD-10 Finland

Medical services not available in home

7.8

9.4

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

9.4

263

1526

AA1XD

NOMESCO Finland

Other special CT of head and brain

3.6

9.4

102

D09

ICPC

Nausea

1.7

9.4

184

969

N03AX16

ATC

pregabalin; oral

1.2

9.4

1591

12204

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.5

9.4

285

1684

X58

ICD-10 Finland

Exposure to other specified factors

1.3

9.4

749

5268

AA400

NOMESCO Finland

Electroconvulsive therapy

3.2

9.3

136

A03FA02

ATC

cisapride; oral, rectal

1.4

9.3

516

3431

G04BD10

ATC

darifenacin; oral

2.8

9.3

191

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.4

9.3

117

L03AA02

ATC

filgrastim; parenteral

0.5

9.3

1110

Z00.0

ICD-10 Finland

General medical examination

1.2

9.2

1255

9415

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

9.2

2611

20952

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

9.2

662

4586

IGV01

NOMESCO Finland

Psychiatric network contact

4.7

9.2

G40.10

ICD-10 Finland

Simple partial seizures

2.9

9.2

162

RS222

NOMESCO Finland

2.3

9.2

314

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

2.5

9.1

247

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

9.1

3612

29731

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

9.1

993

7263

A99

ICPC

Disease/condition unspecnature/site

1.4

9.1

544

3664

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

6.4

9.1

Z43.5

ICD-10 Finland

Attention to cystostomy

3.2

9.1

129

N06AA04

ATC

clomipramine; systemic

2.0

9.1

110

492

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

9.0

271

3481

SPAT1165

SPAT

Peritoneal dialysis

9.5

9.0

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

9.0

325

1996

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.2

9.0

130

F01.31

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism

+∞

9.0

F0024, G308

ICD-10 Finland

+∞

9.0

F0204, G310

ICD-10 Finland

+∞

9.0

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

9.0

F002, G308

ICD-10 Finland

+∞

9.0

F02.00

ICD-10 Finland

Dementia in Pick's disease without additional symptoms

+∞

9.0

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

+∞

9.0

F0024, G301

ICD-10 Finland

+∞

9.0

WF002

NOMESCO Finland

Radical radiotherapy

0.7

9.0

224

2977

N05AF01

ATC

flupentixol; systemic

2.0

9.0

110

496

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

9.0

263

3391

A10BH01

ATC

sitagliptin; oral

1.3

8.8

748

5300

Z50.5

ICD-10 Finland

Speech therapy

2.3

8.8

299

N03AX15

ATC

zonisamide; oral

9.0

8.8

N05CD02

ATC

nitrazepam; oral

2.0

8.8

112

510

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.5

8.8

S82

ICPC

Naevus/mole

0.8

8.7

524

6054

N06AG02

ATC

moclobemide; oral

1.5

8.7

303

1848

R40.0

ICD-10 Finland

Somnolence

4.9

8.7

Z51.5

ICD-10 Finland

Palliative care

1.4

8.7

449

2955

RS221

NOMESCO Finland

2.2

8.7

325

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.5

8.6

1351

N07

ICPC

Convulsion/seizure

5.3

8.6

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

3.8

8.6

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.8

8.6

1763

17933

F10.74

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence

12.2

8.6

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

7.2

8.6

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

8.5

496

3328

D11

ICPC

Diarrhoea

1.3

8.5

519

3507

N06BA04

ATC

methylphenidate; oral

3.6

8.5

N06AX18

ATC

reboxetine; oral

2.3

8.5

287

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

6.2

8.5

A23

ICPC

Risk factor NOS

1.5

8.5

295

1800

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

8.5

128

1889

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.8

8.4

134

664

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

8.4

227

1306

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.7

8.4

269

3416

R26

ICD-10 Finland

Abnormalities of gait and mobility

4.2

8.4

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

10.2

8.4

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.8

8.4

129

630

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.3

8.4

282

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

8.4

119

566

SPF30

NOMESCO Finland

Soling for prothesis

1.7

8.3

160

839

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.6

8.3

185

1013

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3.7

8.3

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.6

8.2

198

1109

PA7BD

NOMESCO Finland

CT angiography of neck and brain

1.8

8.2

134

670

U05

ICPC

Urination problems other

1.4

8.2

349

2218

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.5

8.2

267

1605

A02BA02

ATC

ranitidine; systemic

1.2

8.2

1357

10373

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.4

8.2

262

A02BC01

ATC

omeprazole; systemic

1.2

8.2

1920

15144

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.0

8.2

135

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

9.6

8.1

RT250

NOMESCO Finland

5.8

8.1

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.4

8.1

248

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

8.5

8.1

C07AB07

ATC

bisoprolol; oral

1.1

8.1

3899

32442

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.5

8.0

253

1512

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

3.3

8.0

107

H53.4

ICD-10 Finland

Visual field defects

1.8

8.0

143

735

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.0

8.0

442

RS121

NOMESCO Finland

3.1

8.0

122

F0234, G20

ICD-10 Finland

+∞

8.0

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

+∞

8.0

F02.29*G10

ICD-10 Finland

Dementia in Huntington's disease without information on additional symptoms

+∞

8.0

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

8.0

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

+∞

8.0

F02.3

ICD-10 Finland

Dementia in Parkinson disease

+∞

8.0

F009, F03

ICD-10 Finland

+∞

8.0

Q90

ICD-10 Finland

Down syndrome

+∞

8.0

F02.89*M30.0

ICD-10 Finland

Dementia in polyarteritis nodosa

+∞

8.0

F000, G300

ICD-10 Finland

+∞

8.0

F01.32

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations

+∞

8.0

F0021, G308

ICD-10 Finland

+∞

8.0

F0230, G20

ICD-10 Finland

+∞

8.0

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

8.0

252

1507

N43

ICPC

Neurological, Other diagnostic procedure

3.1

7.9

118

R50.9

ICD-10 Finland

Fever, unspecified

1.3

7.9

851

6213

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.3

7.9

796

5768

S30.1

ICD-10 Finland

Contusion of abdominal wall

2.2

7.9

303

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

8.0

7.9

I67.2

ICD-10 Finland

Cerebral atherosclerosis

3.9

7.8

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.4

7.8

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

7.8

220

1282

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.6

7.8

206

1184

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

6.2

7.8

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.6

7.8

188

1056

AAF00

NOMESCO Finland

Ventriculostomy

2.8

7.7

145

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.3

7.7

472

3193

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

7.7

367

2382

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.8

7.7

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.6

7.7

213

1235

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

2.7

7.7

166

G21.8

ICD-10 Finland

Other secondary parkinsonism

5.7

7.7

H3601, E113

ICD-10 Finland

1.9

7.7

112

541

A10AA01

ATC

1.9

7.6

110

529

K88

ICPC

Postural hypotension

2.3

7.6

249

OAB48

SPAT

0.4

7.6

707

Z01

ICPC

Poverty/financial problem

5.0

7.6

L03AA13

ATC

pegfilgrastim; parenteral

0.6

7.6

104

1567

F61

ICD-10 Finland

Mixed and other personality disorders

3.8

7.6

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.3

7.6

251

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

2.2

7.5

281

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

7.5

397

XF600

SPAT

2.2

7.5

272

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.3

7.4

462

3134

Angiography of the heart and coronary arteries

1.3

7.4

484

3308

-2

ICPC

3.2

7.4

104

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

9.0

7.4

I67.4

ICD-10 Finland

Hypertensive encephalopathy

9.0

7.4

P98

ICPC

Psychosis NOS/other

3.9

7.4

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

7.4

805

5886

P19

ICPC

Drug abuse

3.5

7.4

C07AA05

ATC

propranolol; systemic

1.2

7.4

1030

7740

WZC30

NOMESCO Finland

Teaching

0.8

7.4

665

7315

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

2.8

7.4

140

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

11.7

7.3

R45.5

ICD-10 Finland

Hostility

11.7

7.3

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.1

7.3

339

A10BH05

ATC

linagliptin; oral

1.4

7.3

361

2358

R51

ICD-10 Finland

Headache

1.5

7.3

228

1360

K28

ICPC

Limited function/disability (K)

1.7

7.3

149

801

Z93.5

ICD-10 Finland

Cystostomy status

4.4

7.3

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.0

7.3

408

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

7.3

820

6018

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.1

7.3

363

H50.52

ICD-10 Finland

Exophoria

2.5

7.3

184

R4150

NOMESCO Finland

Neuropsychological rehabilitation

3.1

7.3

106

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.0

7.2

398

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.2

7.2

274

JN4AD

NOMESCO Finland

Body CT examination

0.7

7.2

374

4404

D07AA02

ATC

hydrocortisone; topical

1.3

7.2

678

4876

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

7.2

623

4433

B01AC07

ATC

dipyridamole; systemic

1.5

7.1

244

1488

F07.0

ICD-10 Finland

Organic personality disorder

16.4

7.1

I95.2

ICD-10 Finland

Hypotension due to drugs

2.5

7.1

197

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.3

7.1

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

7.1

1840

14604

RS230

NOMESCO Finland

3.2

7.1

T68

ICD-10 Finland

Hypothermia

3.2

7.1

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.0

7.1

351

F80.1

ICD-10 Finland

Expressive language disorder

2.7

7.1

147

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.8

7.1

139

Z27

ICPC

Fear of a social problem

4.4

7.0

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

7.0

407

2733

F0282, G318

ICD-10 Finland

+∞

7.0

F0021, G301

ICD-10 Finland

+∞

7.0

F0022, G308

ICD-10 Finland

+∞

7.0

F0012, G301

ICD-10 Finland

+∞

7.0

F02.89*T58

ICD-10 Finland

Dementia with carbon monoxide intoxication

+∞

7.0

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

+∞

7.0

F0023, G308

ICD-10 Finland

+∞

7.0

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

0.3

7.0

388

G44.2

ICD-10 Finland

Tension-type headache

1.3

7.0

694

5022

G02CB01

ATC

bromocriptine; systemic

2.6

7.0

171

C08CA05

ATC

nifedipine; systemic

1.3

7.0

414

2792

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

7.9

6.9

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

6.9

198

1160

G72.9

ICD-10 Finland

Myopathy, unspecified

2.4

6.9

205

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

6.9

2124

17074

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

5.0

6.9

OAB95

SPAT

0.3

6.9

370

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.6

6.9

158

877

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.0

6.9

387

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.6

6.9

S01.3

ICD-10 Finland

Open wound of ear

2.1

6.9

289

L03AA14

ATC

lipegfilgrastim; parenteral

0.4

6.9

640

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.6

6.8

158

R54

ICD-10 Finland

Senility

5.5

6.8

I61

ICD-10 Finland

Intracerebral haemorrhage

5.5

6.8

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.5

6.8

930

J01FA10

ATC

azithromycin; systemic

0.9

6.8

2945

28534

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.8

6.8

661

7214

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

6.8

5054

43029

K02.1

ICD-10 Finland

Caries of dentine

1.1

6.8

3427

28474

H81.4

ICD-10 Finland

Vertigo of central origin

2.4

6.8

192

RF220

NOMESCO Finland

1.9

6.8

471

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.9

6.8

458

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

9.7

6.8

2967A

ICD-9 Finland

Affective psychoses, Bipolar affective disorder, unspecified

6.8

WX111

NOMESCO Finland

Local infiltration anesthesia

0.6

6.7

111

1603

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.5

6.7

197

1162

C08CA01

ATC

amlodipine; oral

1.1

6.7

2963

24404

N04BC07

ATC

apomorphine; parenteral

17.9

6.7

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

6.6

392

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.3

6.6

D01AA02

ATC

natamycin; topical

1.8

6.6

114

583

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.6

6.6

150

831

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.7

6.6

128

679

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.5

6.6

894

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.8

6.5

113

577

A13

ICPC

Concern/fear medical treatment

1.8

6.5

108

547

G91.1

ICD-10 Finland

Obstructive hydrocephalus

3.5

6.5

P16

ICPC

Acute alcohol abuse

2.1

6.5

277

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

4.8

6.5

SPAT1111

SPAT

Planning of analgesia

2.1

6.5

289

SPF10

NOMESCO Finland

Demanding repatation of teeth prosthesis

1.6

6.5

160

904

N05CD08

ATC

midazolam; nasal, systemic

1.6

6.5

139

760

G25.2

ICD-10 Finland

Other specified forms of tremor

2.8

6.5

126

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.3

6.5

213

R07.3

ICD-10 Finland

Other chest pain

1.3

6.4

607

4365

N03AX22

ATC

perampanel; oral

12.3

6.4

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

3.7

6.4

IEY01

NOMESCO Finland

Psychoeducation, individual

5.4

6.4

T93

ICPC

Lipid disorder

0.7

6.4

248

3045

G93.4

ICD-10 Finland

Encephalopathy, unspecified

4.1

6.4

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

6.4

267

1697

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

6.2

6.4

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.4

6.4

297

1926

R74

ICPC

Upper respiratory infection acute

0.8

6.3

937

9825

SPAT1211

SPAT

Application of soft bandage

1.3

6.3

624

4509

A10BD07

ATC

metformin and sitagliptin; systemic

1.4

6.3

306

1996

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.7

6.3

171

2232

G46.7

ICD-10 Finland

Other lacunar syndromes

14.9

6.3

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

6.3

269

1716

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.4

6.3

333

2206

XX3DW

NOMESCO Finland

Time consuming IT work

0.8

6.3

506

5640

F06.30

ICD-10 Finland

Organic manic syndrome

6.7

6.3

SPAT1109

SPAT

Analgesia with portable analgesic pump

2.6

6.3

144

S02.11

ICD-10 Finland

Fracture of base of skull, open

3.3

6.3

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

5.6

6.3

G31

ICD-10 Finland

Other degenerative diseases of nervous system, not elsewhere classified

20.2

6.3

AA5NK

NOMESCO Finland

Tractography within white matter of central nervous system

20.2

6.3

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

6.3

139

767

WYA30

SPAT

3.0

6.3

103

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

3.2

6.3

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

6.3

1259

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.4

6.3

194

C10AA04

ATC

fluvastatin; oral

1.2

6.3

697

5113

M79.6

ICD-10 Finland

Pain in limb

1.1

6.3

2432

19844

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

1.9

6.2

371

DJA10

NOMESCO Finland

Biopsy of septum of nose

5.2

6.2

R63.1

ICD-10 Finland

Polydipsia

4.2

6.2

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.2

6.2

1361

10647

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

4.4

6.2

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.7

6.2

266

3217

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

6.0

6.2

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

3.8

6.2

N32.0

ICD-10 Finland

Bladder-neck obstruction

2.0

6.2

339

J01DA01

ATC

[U] cefalexin; systemic

1.1

6.2

4153

35038

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.4

6.2

274

1762

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.7

6.2

126

680

A08

ICPC

Swelling

1.4

6.1

284

1838

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

62.8

6.1

30041

ICD-8 Finland

Neuroses, Depressiva

1.9

6.1

381

N05AB01

ATC

dixyrazine; systemic

2.0

6.1

344

RS122

NOMESCO Finland

4.7

6.1

A02BC03

ATC

lansoprazole; oral

1.1

6.1

2000

16134

Y94.1

ICD-10 Finland

Accident in connection with service housing

9.0

6.0

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.0

1807

14475

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.9

6.0

110

H25.1

ICD-10 Finland

Senile nuclear cataract

1.1

6.0

2128

17246

H53.2

ICD-10 Finland

Diplopia

1.5

6.0

183

1092

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

4.0

6.0

S82.0

ICD-10 Finland

Fracture of patella

1.8

6.0

496

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

982

1668

4.22

316.04

1.2

1.4

12.1

23.0

e6/l

0.94

776

1302

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

981

1668

4.21

315.31

1.3

1.4

588.5

2369.5

e6/l

0.78

804

1377

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

987

1704

4.15

311.15

1.2

1.3

3.9

3.8

mmol/l

0.36

924

1594

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10660

52690

1.85

307.65

2.4

2.1

91.4

93.4

pmol/l

3.86

5721

26959

(3021960) Folate [Moles/volume] in Serum or Plasma

7181

31418

1.90

307.65

1.7

1.6

19.9

20.5

nmol/l

1.71

6135

26303

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6396

26256

2.00

307.65

1.8

1.7

4863320.8

31361496.9

pmol/l

8.00

5141

20653

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1117

1958

4.11

307.65

1.2

1.3

509.1

579.8

mg/l

1.55

1021

1869

(3009466) Valproate [Moles/volume] in Serum or Plasma

743

956

5.53

307.65

4.0

338.0

342.4

umol/l

0.28

607

803

(3019309) Folate [Moles/volume] in Red Blood Cells

8221

26006

3.01

307.65

1.9

1.8

1177.0

1151.3

nmol/l

1.52

6159

19013

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

965

458

15.22

307.65

1.0

594.7

800.5

ng/l

15.24

685

274

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

966

460

15.17

307.65

1.0

50.8

36.8

ng/l

9.47

697

278

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

953

462

14.89

307.65

1.0

373.2

303.2

ng/l

2.75

698

288

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5473

23798

1.81

258.42

2.8

3.2

2.5

mmol/l

11.11

4714

20589

(3015377) Calcium [Moles/volume] in Serum or Plasma

8297

40662

1.70

257.29

2.5

3.4

2.4

mmol/l

0.36

6875

34302

(3044290) Cell count panel - Cerebral spinal fluid

865

1573

3.92

254.26

1.2

1.3

—

(3026008) Bacteria identified in Urine by Culture

8126

40478

1.65

228.35

4.0

3.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11380

62818

1.58

198.24

5.4

6.8

1.2

mmol/l

30.69

9246

52490

(3023368) Bacteria identified in Blood by Culture

7295

36902

1.57

179.42

4.1

4.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

9876

53594

1.54

176.46

3.7

4.7

34.4

34.3

g/l

0.99

8801

49245

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4790

22141

1.65

168.73

1.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

13171

76613

1.55

166.28

6.4

5.2

2925.2

1164.6

e6/l

2.52

319

1187

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8368

44645

1.50

154.19

2.2

77.8

80.8

nmol/l

14.89

7034

38464

(3023410) Appearance of Cerebral spinal fluid

444

708

4.40

153.58

1.3

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10266

57190

1.49

152.57

4.9

6.1

1.2

mmol/l

15.57

9023

51119

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8884

48312

1.48

146.47

4.8

4.3

82.0

80.6

ng/l

0.02

7255

38150

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1987

7510

1.92

136.64

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

4807

45096

0.65

133.19

2.1

2.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7122

37659

1.47

130.33

2.4

2.1

261.0

213.3

u/l

3.99

6649

34893

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2694

28340

0.60

121.77

1.5

1.6

1.3

mmol/l

0.24

2213

23046

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3269

15292

1.57

102.45

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3269

15394

1.56

99.16

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

396

845

3.28

91.99

1.2

1.3

—

(3018418) pH of Serum or Plasma

6820

37558

1.38

90.00

3.2

4.2

7.4

0.93

1256

7073

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6070

33285

1.37

79.73

2.3

3.1

mg/l

0.26

4920

28126

(3019150) Specific gravity of Urine by Refractometry

4488

23731

1.39

72.13

5.5

4.7

1.0

kg/l

1.37

765

3847

(3037467) Urinalysis macro (dipstick) panel - Urine

12547

77649

1.31

65.65

5.5

4.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1032

3981

1.83

64.97

1.2

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7018

40245

1.31

64.53

5.5

4.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

11372

69616

1.29

63.35

4.8

7.1

6.9

mmol/l

11.67

10754

65525

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13074

98171

0.76

63.06

4.3

4.9

1.4

mmol/l

1.36

11321

87057

(3006270) Folate [Moles/volume] in Blood

380

988

2.68

62.91

1.3

1.2

309.8

311.3

nmol/l

0.05

296

737

(4035726)

938

11099

0.56

61.94

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7715

45119

1.29

59.88

2.5

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1421

15002

0.63

59.16

1.2

14.5

16.1

u/ml

0.28

422

4911

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

273

633

3.00

55.54

2.4

2.3

—

(3012516) Albumin [Mass/volume] in Urine

4596

39067

0.75

55.46

2.9

3.3

471.6

396.4

mg/l

0.47

2975

24748

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1853

8688

1.52

54.76

1.8

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13312

99195

0.78

54.74

4.3

4.9

4.3

4.4

mmol/l

23.33

11607

88778

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12274

76611

1.27

53.70

3.9

4.1

15.3

15.2

pmol/l

2.66

10671

67431

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12673

94908

0.78

53.32

3.8

4.4

1.2

1.3

mmol/l

5.16

10843

83234

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1585

16001

0.66

53.02

1.2

1.3

49.9

41.8

iu/ml

0.91

468

4835

(3014271) Vancomycin [Susceptibility]

328

875

2.61

51.73

3.2

3.0

—

(3029937) Albumin [Presence] in Urine by Test strip

5269

29748

1.30

51.41

5.3

4.6

0.0

estimate

1.91

1473

9652

(3035350) Ketones [Presence] in Urine by Test strip

8914

53784

1.26

50.55

4.9

4.1

0.0

estimate

0.50

1612

10135

(3009508) Creatinine [Moles/volume] in Urine

4685

39314

0.77

49.95

2.8

3.2

7.0

6.9

mmol/l

0.84

3673

32063

(3002256) Pathology report gross observation

1590

15746

0.67

47.84

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

843

9613

0.59

47.73

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

8969

54536

1.24

45.67

5.0

4.2

0.0

estimate

1.34

1586

10007

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14576

93658

1.27

44.97

5.0

2.0

2.1

mu/l

2.66

12911

82931

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1951

9597

1.45

44.95

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

5012

41274

0.78

44.57

3.5

4.0

12.1

9.6

mg/mmol

1.78

3166

25814

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

175

353

3.44

44.47

1.2

35.6

61.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1443

6735

1.51

43.15

1.8

1.6

1.7

1.6

0.48

1166

5469

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13904

102249

0.79

42.98

4.9

5.6

2.4

2.5

mmol/l

28.60

12122

91183

(1761868) Lipid panel - Serum or Plasma

2980

26119

0.75

42.33

3.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

8824

53857

1.23

42.02

6.5

5.6

0.0

estimate

0.80

1590

10195

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

873

9420

0.62

38.96

1.5

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3602

19950

1.30

38.75

30.0

31.6

1.6

1.5

inr

1.36

414

2681

(3026782) Osmolality of Urine

4517

25849

1.27

37.26

3.2

2.9

558.2

543.5

mosm/kgh2o

4.89

3851

21837

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1217

5675

1.51

36.39

2.0

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1139

5246

1.53

36.08

1.9

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

175

3084

0.39

35.82

1.4

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

150

320

3.25

35.12

3.1

2.6

28.6

29.6

umol/l

0.41

107

239

(3003694) ABO and Rh group [Type] in Blood

3037

25943

0.77

34.42

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

298

928

2.23

33.84

1.3

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

2027

10538

1.36

33.35

3.0

3.1

4.3

4.4

kpa

3.13

1946

10161

(3037522) Nuclear Ab [Titer] in Serum

1285

12439

0.69

33.28

1.3

510.5

526.8

titre

0.13

290

2885

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2369

12650

1.33

32.62

2.5

5.3

6.6

ug/l

3.68

1737

10890

(3023183) Ammonium ion [Moles/volume] in Plasma

593

2383

1.74

32.44

1.9

2.2

28.6

33.6

umol/l

5.16

454

1927

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15691

102885

1.24

31.56

20.9

18.3

29.5

27.3

mg/l

11.22

13587

84836

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

930

9474

0.66

31.45

1.3

—

(21494755) Public health laboratory ask at order entry panel

1852

0.27

31.11

1.2

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

237

693

2.37

31.10

1.2

2.1

2.3

mmol/l

1.09

216

636

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1972

0.29

30.79

1.4

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

994

4602

1.52

30.67

2.1

2.2

816.4

542.5

ug/l

0.64

927

4362

(3000492) Spirometry study

782

8153

0.65

29.54

1.5

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2022

10772

1.33

28.04

3.3

4.0

1.2

mmol/l

0.43

1684

9316

(4010399)

842

8533

0.67

27.61

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

218

650

2.33

27.46

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

6346

38682

1.19

26.38

3.8

3.5

106.8

118.8

e6/l

0.21

5059

30032

(40761535) Cells panel - Urine sediment

1985

10637

1.32

26.33

3.8

3.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1707

15231

0.75

26.00

2.7

4.0

17.2

25.7

ug/l

0.96

1405

12733

(3022145) Colonoscopy Study observation

1354

12486

0.73

25.79

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

4621

27401

1.21

25.71

3.0

2.7

5.4

4.9

e6/l

2.09

4053

23893

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1275

6407

1.40

25.57

4.1

4.3

45.9

46.6

0.49

1261

6326

(3041096) Erythrocytes [Presence] in Urine by Automated

4558

27026

1.21

25.30

4.8

4.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13291

96691

0.84

25.11

19.4

17.8

69.4

70.4

ml/min/173m2

5.97

10910

80516

(3019832) Treponema pallidum Ab [Presence] in Serum

561

2382

1.64

25.10

1.2

1.4

—

(3019225) pH of Specimen

2396

13283

1.28

24.48

4.1

4.5

—

(3018095) Leukocytes [#/volume] in Urine

7046

43549

1.18

24.39

4.3

4.0

152.4

123.9

e6/l

0.98

5298

31863

(3012544) pH of Venous blood

2393

13332

1.27

23.42

3.2

3.7

7.4

0.17

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5989

36622

1.18

23.25

2.4

2.6

57.7

60.3

u/l

2.02

5453

33452

(40768797) Stomach Pathology biopsy report

1844

16038

0.77

22.96

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3879

31074

0.83

22.70

2.5

3.0

8266.2

6454.4

umol/l

1.17

3070

25982

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2314

12886

1.27

22.68

3.2

3.7

5.8

kpa

0.03

2234

12492

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

107

245

3.02

22.53

1.3

1.2

48.3

20.8

—

(3002032) Base excess in Venous blood by calculation

2308

12867

1.27

22.40

3.2

3.7

2.1

1.9

mmol/l

1.08

1889

10399

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

142

384

2.56

22.10

2.6

2.1

62.9

56.6

umol/l

1.19

289

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

155

3.52

21.15

11.7

11.4

674.1

832.5

nmol/l

1.97

146

(3013139) Helicobacter pylori Ag [Presence] in Stool

693

6923

0.68

20.98

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2699

15499

1.23

19.99

10.1

8.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1612

8706

1.30

19.99

5.3

6.8

24.6

mmol/l

0.01

1527

8110

(3027273) Bicarbonate [Moles/volume] in Venous blood

1325

6962

1.33

19.99

3.3

3.5

25.3

25.1

mmol/l

1.17

1288

6766

(3032080) INR in Blood by Coagulation assay

8577

54385

1.15

19.95

11.4

1.3

1.4

inr

1.39

2288

14616

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

656

3063

1.49

19.48

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

656

3063

1.49

19.48

1.4

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

204

3.05

19.34

16.7

11.3

0.7

0.6

mmol/l

0.96

185

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1122

5796

1.35

18.93

3.9

5.0

1.6

0.58

1072

5445

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13232

86722

1.16

18.71

6.0

7.9

81.0

81.8

u/l

0.66

12084

81158

(3021589) Normoblasts [#/volume] in Blood

6267

47665

0.86

18.58

10.9

10.8

0.0

e9/l

1.24

5167

38658

(4027681)

113

301

2.60

18.21

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1211

6379

1.33

17.94

2.6

1.1

1.2

0.26

1205

6343

(3004119) Hemoglobin [Mass/volume] in Venous blood

1522

8290

1.29

17.64

3.2

3.3

127.0

126.1

g/l

0.88

1487

8073

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

444

4680

0.65

17.59

2.9

4.0

128.6

86.2

u/ml

0.60

420

4486

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7106

53429

0.87

17.55

4.1

4.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1188

6261

1.33

17.53

2.6

0.7

2.07

1136

6009

(3007930) Methemoglobin/Hemoglobin.total in Blood

1100

5734

1.34

17.49

3.9

5.0

0.9

1.08

1055

5376

(3022621) pH of Urine by Test strip

1437

7816

1.29

16.83

4.0

3.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4394

26759

1.17

16.82

4.7

4.1

—

(40768800) Prostate Pathology biopsy report

271

3170

0.58

16.78

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

447

1991

1.56

16.55

2.7

2.5

—

(4094501)

225

2750

0.56

16.42

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

101

272

2.57

15.99

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

143

453

2.19

15.87

1.1

35.9

46.3

mg/l

3.22

115

389

(3028707) Methadone [Presence] in Urine by Screen method

241

2.67

15.87

2.0

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

136

423

2.23

15.78

1.1

264.1

327.0

mg/l

3.22

114

372

(3038515) Glucose [Moles/volume] in Venous blood

660

3222

1.43

15.63

4.0

3.7

8.1

7.6

mmol/l

2.83

647

3155

(3020191) Ethanol [Moles/volume] in Serum or Plasma

163

555

2.03

15.08

1.4

1.3

1.0

1.1

promille

0.60

129

410

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

155

519

2.07

14.99

1.3

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

684

3388

1.41

14.95

3.9

3.5

1.7

1.6

mmol/l

1.08

670

3313

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

236

2767

0.58

14.79

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

511

5058

0.69

14.73

1.9

3.2

1160.7

2225.4

u/ml

0.49

407

4325

(36304419) Bacteria [Presence] in Urine

5431

33891

1.14

14.52

3.7

3.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.45

13.87

2.4

2.0

22.1

17.6

umol/l

1.14

(3040151) Glucose [Moles/volume] in Capillary blood

362

1604

1.57

13.79

6.0

12.7

8.0

7.3

mmol/l

1.90

280

1329

(3030467) Casts [#/volume] in Urine by Automated count

5688

35706

1.14

13.74

3.7

3.4

0.5

e6/l

1.07

4509

27269

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1038

0.36

13.70

1.2

1.5

—

(40768793) Breast Pathology biopsy report

190

2301

0.57

13.49

1.2

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

12183

80117

1.13

13.49

4.0

4.4

15.2

mm/h

0.15

10860

72749

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

237

2698

0.60

13.26

2.2

203.3

209.5

0.54

216

2554

(3007164) IgA [Mass/volume] in Serum or Plasma

2090

16959

0.83

13.13

1.4

1.5

2.9

2.7

g/l

1.51

1072

9211

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

255

2832

0.62

12.88

1.2

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

517

1.98

12.85

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

124

1678

0.51

12.83

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

145

2.95

12.80

1.1

1.3

24.0

52.1

3.42

(3005322) IgE [Units/volume] in Serum or Plasma

495

4791

0.71

12.60

1.3

245.5

249.5

u/ml

0.04

440

4351

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

318

3341

0.65

12.50

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

943

8290

0.77

12.48

1.4

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

2013

0.55

12.46

2.6

4.0

552.2

1853.7

iu/ml

0.86

307

(40768443) Skin Pathology biopsy report

593

5551

0.73

12.29

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

264

2867

0.63

12.11

1.9

2.0

93.5

87.2

4.59

241

2703

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

280

2993

0.64

11.96

1.9

3.0

555.3

713.4

u/ml

0.15

241

2724

(4034850)

656

3352

1.36

11.96

13.7

12.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

785

4137

1.32

11.65

3.5

4.2

3.9

mmol/l

0.12

708

3882

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3354

25970

0.87

11.56

3.0

3.5

0.8

ug/l

1.24

2410

19265

(3024891) Influenza virus A+B Ag [Presence] in Specimen

490

2399

1.42

11.53

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

122

414

2.04

11.52

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

16177

108628

1.14

11.36

25.0

22.0

139.6

139.5

mmol/l

7.81

15651

105768

(3002179) Metamyelocytes/100 leukocytes in Blood

1072

9166

0.80

11.24

3.1

3.7

0.7

0.6

0.31

231

2260

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

509

1.92

11.21

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

758

3998

1.32

11.19

5.7

4.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

158

1901

0.57

11.04

1.1

—

(3047181) Lactate [Moles/volume] in Blood

766

4061

1.31

10.91

4.4

6.0

1.4

1.3

mmol/l

0.69

698

3601

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

217

2404

0.62

10.91

1.2

8.6

5.2

u/ml

0.28

410

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6887

44188

1.11

10.89

3.1

3.3

2069.5

1879.1

ng/l

2.35

5811

38665

(3023103) Potassium [Moles/volume] in Serum or Plasma

16185

108754

1.14

10.88

25.1

22.2

4.0

mmol/l

1.66

15632

105733

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1575

9093

1.21

10.79

1.8

2.2

389.0

382.0

nmol/l

0.70

1365

8250

(40768795) Lymph node Pathology biopsy report

1179

0.47

10.73

1.1

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

1211

10165

0.81

10.70

3.2

3.8

1.0

0.9

0.21

345

3172

(3021879) Hepatitis B virus core Ab [Presence] in Serum

546

5065

0.74

10.70

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

173

2.60

10.69

2.2

2.3

137.6

131.7

nmol/l

0.19

149

(3018405) Lactate [Moles/volume] in Arterial blood

896

4868

1.28

10.62

3.3

3.9

1.4

mmol/l

0.30

879

4776

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

302

3090

0.67

10.48

2.4

2.1

3.6

3.7

g/l

0.64

281

2933

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

217

2379

0.62

10.45

1.2

12.0

4.4

u/ml

0.37

270

(3019060) Gas panel - Arterial blood

1641

9543

1.20

10.42

3.7

4.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

677

6061

0.76

10.34

1.7

1.9

1.6

1.4

g/l

0.63

576

5376

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1240

7026

1.23

10.23

3.1

2.9

0.4

0.3

e6/l

0.76

1220

6907

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

238

2540

0.64

10.16

1.2

31.2

40.4

u/ml

0.22

143

(3021440) Promyelocytes/100 leukocytes in Blood

1149

9641

0.81

10.12

3.3

3.9

0.1

0.14

317

2948

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1107

9319

0.81

10.06

3.0

2.9

59.2

57.5

ml/min/173m2

0.98

481

4167

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6806

43782

1.11

10.02

2.8

2.9

146.3

161.7

ug/l

4.98

5876

39276

(3027945) Reticulocytes/100 erythrocytes in Blood

2783

16957

1.15

10.00

2.0

2.4

1.7

1.8

0.98

2277

14848

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

159

2.61

9.98

2.2

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13729

97714

0.90

9.79

6.8

6.9

42.3

41.0

mmol/mol

32.66

12078

87955

(3045142) Bone marrow Pathology biopsy report

123

1531

0.55

9.78

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4116

25798

1.13

9.58

4.4

4.2

213.5

457.3

ng/l

6.16

3637

22553

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

125

1538

0.56

9.55

1.8

2.1

835.1

1777.0

u/ml

—

107

(3017446) Testosterone [Moles/volume] in Serum or Plasma

788

6848

0.79

9.52

2.0

2.1

10.9

11.0

nmol/l

0.11

650

5750

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

159

2.56

9.51

2.2

2.1

—

(3025159) Blasts/100 leukocytes in Blood

1066

8950

0.81

9.44

3.3

3.9

0.5

0.3

0.22

265

2489

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

186

2055

0.62

9.32

1.2

1.8

6.5

u/ml

1.96

167

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2199

13235

1.16

9.29

4.8

3.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

516

2651

1.35

9.18

4.0

3.8

31.4

29.5

mg/l

0.49

365

1709

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

270

2743

0.67

9.09

1.6

1.8

12.5

12.3

mg/l

0.13

236

2493

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

167

1879

0.61

9.06

1.5

1.6

3.3

3.5

mg/l

0.10

129

1381

(4281824)

1209

0.52

9.04

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9004

58960

1.10

8.87

3.2

3.1

53.0

57.4

u/l

3.30

7947

52932

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14258

101125

0.90

8.85

5.0

5.4

6.2

6.1

mmol/l

11.10

12318

89211

(3009343) pH of Capillary blood

1475

8629

1.19

8.78

3.2

3.8

7.4

0.04

186

1153

(3000494) Fungus identified in Specimen by Culture

1578

12687

0.85

8.76

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

710

3843

1.28

8.73

3.6

3.1

0.8

nmol/l

0.10

538

3003

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1428

8336

1.20

8.70

3.2

3.8

2.0

mmol/l

0.31

1023

6218

(3009445) Proteinase 3 Ab [Units/volume] in Serum

620

5480

0.77

8.62

1.3

1.5

35.1

17.6

u/ml

0.65

121

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

473

4332

0.75

8.57

1.4

1.7

37.4

38.2

u/l

0.32

384

3633

(3008898) HLA-B27 [Presence]

150

1707

0.60

8.55

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

937

0.47

8.54

2.0

1.3

22.2

29.1

iu/ml

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

930

7830

0.81

8.48

1.4

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

379

3582

0.72

8.47

1.6

1.4

23.9

16.3

iu/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1228

0.54

8.46

1.5

1.7

—

(3018572) Chloride [Moles/volume] in Blood

560

2950

1.32

8.44

4.6

6.7

105.1

104.8

mmol/l

0.65

519

2641

(3039000) Anion gap in Blood

560

2950

1.32

8.44

4.6

6.7

11.3

mmol/l

0.13

519

2641

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3254

20248

1.13

8.42

1.8

1.9

29.7

30.2

4.52

3137

19653

(3008116) Ketones [Moles/volume] in Urine by Test strip

204

2.27

8.39

1.5

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1487

8741

1.19

8.38

3.2

3.8

5.2

5.1

kpa

2.32

1306

8058

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3324

20719

1.13

8.36

3.4

3.2

3.1

2.4

e6/l

2.28

1923

11635

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1059

6035

1.22

8.31

1.8

1.9

3.0

2.2

ug/l

0.80

826

5273

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

241

2.15

8.28

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

112

2.71

7.97

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

259

2.08

7.95

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

377

3527

0.73

7.91

1.2

0.4

1.0

u/ml

2.24

352

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

102

375

1.88

7.83

1.5

1.7

106.8

99.6

umol/l

0.14

214

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

164

1787

0.63

7.81

1.4

1.5

317.1

232.3

pmol/l

0.34

156

1733

(40761511) CBC panel - Blood by Automated count

15429

103874

1.11

7.79

20.2

17.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

100

366

1.89

7.79

1.9

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

553

2943

1.30

7.78

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

262

2.06

7.73

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

912

7617

0.82

7.70

2.4

2.8

10.6

10.7

g/l

0.07

797

6918

(3003181) Sodium [Moles/volume] in Urine

494

2593

1.32

7.68

1.4

1.3

65.0

61.2

mmol/l

1.43

397

2092

(42529406) Shigella sp [Presence] in Stool by Culture

559

2985

1.30

7.68

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

557

2973

1.30

7.67

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

8810

63665

0.92

7.65

6.7

8.8

4.7

4.4

e9/l

21.21

7600

54819

(3028271) Lactate [Moles/volume] in Capillary blood

427

2196

1.35

7.63

1.9

1.7

mmol/l

2.63

419

2143

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

207

931

1.54

7.62

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

210

950

1.53

7.54

1.3

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

156

1703

0.63

7.51

2.9

3.5

29.8

44.5

u/ml

1.64

147

1653

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

537

4745

0.77

7.50

1.1

1.2

92.6

126.4

iu/ml

1.30

176

1526

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

307

2938

0.72

7.46

1.8

1.5

1.1

1.2

g/l

0.57

290

2754

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

871

0.49

7.41

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

124

1424

0.60

7.41

1.2

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

2256

13826

1.14

7.36

1.8

1.9

—

(3011288) Drugs identified in Urine by Screen method

310

1.94

7.35

2.6

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

251

2478

0.69

7.33

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

375

3467

0.74

7.31

1.7

1.6

—

(3000330) Specific gravity of Urine by Test strip

1178

6881

1.19

7.16

4.8

4.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

139

1537

0.62

7.11

1.2

1.3

0.3

nmol/l

0.11

121

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

156

1678

0.64

7.06

1.2

30.5

46.1

u/ml

0.54

186

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

603

0.41

6.92

1.8

1.3

1.2

1.3

u/ml

0.09

333

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

139

1527

0.63

6.92

1.2

1.3

0.6

1.8

nmol/l

0.89

124

1454

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

302

2860

0.72

6.91

1.8

1.4

0.2

g/l

0.48

284

2669

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.03

6.91

1.6

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3908

29185

0.90

6.83

2.3

2.5

—

(3025941) Bacteria identified in Stool by Culture

925

5310

1.21

6.80

1.3

—

(3023419) Bacteria identified in Sputum by Culture

174

1810

0.66

6.73

1.9

2.4

—

(3010421) pH of Blood

648

3587

1.25

6.72

3.8

4.2

7.4

0.99

551

3062

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2159

16641

0.88

6.64

2.8

3.9

246.8

249.7

u/l

0.36

1934

15647

(3022806) Fractional oxyhemoglobin in Capillary blood

345

1757

1.36

6.63

1.9

88.9

89.0

0.13

340

1733

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

613

5250

0.80

6.61

2.5

2.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

477

4202

0.78

6.55

1.6

186.7

242.1

titre

0.44

197

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

106

1224

0.60

6.53

1.0

1.1

1.6

g/l

0.78

1079

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

154

1631

0.65

6.52

1.5

1.7

52.8

47.8

nmol/l

1.35

144

1537

(21494434) Karyotype in Bone marrow

114

1291

0.61

6.49

1.1

—

(3036603) Volume of Urine

840

0.52

6.48

1.4

1.6

1693.1

1877.3

0.50

232

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

197

1984

0.68

6.48

1.4

1.8

17.2

24.6

ug/l

3.92

189

1930

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9315

61605

1.08

6.40

4.3

6.2

12.1

12.3

umol/l

0.32

8602

58414

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

152

2.27

6.39

1.1

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

313

2904

0.74

6.31

2.1

1.6

—

(3012501) Base excess in Blood by calculation

571

3139

1.26

6.31

3.9

4.3

2.5

2.7

mmol/l

1.56

398

2172

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

264

1.94

6.30

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

126

1383

0.63

6.30

1.2

1.3

108.2

123.9

u/ml

1.13

310

(3013290) Carbon dioxide [Partial pressure] in Blood

571

3141

1.26

6.27

3.9

4.3

5.0

kpa

0.29

551

3060

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

394

1.75

6.25

1.9

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

394

1.75

6.25

1.9

2.2

—

(3008295) Osmolality of Serum or Plasma

249

1219

1.41

6.10

1.4

1.3

275.7

275.3

mosm/kgh2o

0.11

168

902

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

164

1688

0.67

6.07

1.1

—

(3016038) Potassium [Moles/volume] in Urine

196

918

1.48

6.06

1.1

32.7

35.3

mmol/l

0.93

156

766

(4198724)

2.63

6.05

1.6

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

134

577

1.61

6.04

1.7

1.4

15.5

14.7

umol/l

0.41

126

533

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

293

1.86

6.02

1.6

1.2

98.8

134.8

nmol/l

1.47

212

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1681

10252

1.14

5.90

2.9

3.7

90.0

99.2

ng/l

3.97

1310

8583

(3027315) Oxygen [Partial pressure] in Blood

570

3159

1.25

5.90

3.9

4.4

8.1

8.4

kpa

2.46

549

3078

(3020891) Body temperature

938

5472

1.19

5.84

4.2

4.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2153

13351

1.13

5.82

3.1

243.6

261.3

ng/l

0.80

1960

12322

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

264

1.88

5.70

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

1069

0.60

5.69

1.7

1.8

4.4

4.6

mg/l

0.12

1004

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

156

2.17

5.66

1.1

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

100

1126

0.61

5.63

1.3

1.2

24.2

54.7

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

157

1602

0.67

5.60

1.2

1.3

—

(3036489) Thrombin time

443

3856

0.79

5.57

1.7

1.8

21.2

22.2

1.89

398

3474

(3003396) Base excess in Arterial blood by calculation

2555

16043

1.11

5.54

4.6

6.4

1.4

1.1

mmol/l

3.03

1935

12567

(3042631) Mycobacterium sp identified in Specimen

231

2194

0.72

5.48

2.2

2.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.98

5.44

8.3

—

(40757373) Influenza virus identified in Isolate

244

1.90

5.43

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1064

0.61

5.43

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

142

1468

0.66

5.43

1.5

1.6

0.8

0.9

g/l

0.49

109

1087

(3022096) Basophils/100 leukocytes in Blood

6930

50111

0.93

5.42

5.1

5.9

0.6

7.54

6261

46169

(40768441) Liver Pathology biopsy report

702

0.52

5.42

1.0

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3487

22276

1.10

5.34

3.2

3.0

1.5

1.4

e6/l

0.54

2060

13100

(1002224) Polysomnography panel

210

2016

0.72

5.34

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

356

1889

1.31

5.27

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

213

0.26

5.21

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

105

443

1.64

5.20

1.9

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

701

0.53

5.19

1.2

1.1

0.3

1.4

u/ml

2.40

269

(3006504) Eosinophils/100 leukocytes in Blood

7129

51439

0.93

5.19

5.1

5.9

2.7

2.8

2.02

6432

47337

(3006315) Basophils [#/volume] in Blood

7615

54794

0.93

5.09

4.8

5.6

0.0

e9/l

2.44

6463

46193

(3019069) Monocytes/100 leukocytes in Blood

7171

51705

0.93

5.08

5.5

6.2

8.8

9.0

3.42

6496

47702

(3011985) Renin [Units/volume] in Plasma

142

1447

0.67

5.07

1.2

1.4

50.3

56.9

mu/l

0.19

118

1271

(3001604) Monocytes [#/volume] in Blood

7561

54409

0.93

5.05

4.8

5.6

0.6

e9/l

0.00

6404

45815

(1616796) Gas panel - Central venous blood

563

3177

1.23

5.01

3.1

3.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

611

3478

1.22

5.00

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

133

1367

0.67

4.97

1.5

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

885

5214

1.18

4.97

3.7

4.2

25.1

24.9

mmol/l

1.57

756

4777

(3018010) Neutrophils/100 leukocytes in Blood

7163

51595

0.93

4.87

5.2

5.8

60.6

59.0

19.86

6458

47520

(3010813) Leukocytes [#/volume] in Blood

16257

110309

1.09

4.85

29.7

27.2

7.2

6.9

e9/l

17.57

15554

106238

(3048929) Epstein Barr virus Ab [Presence] in Serum

176

1710

0.71

4.85

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

558

0.49

4.85

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1047

6265

1.16

4.84

3.0

3.9

24.3

24.1

mmol/l

0.82

931

5595

(40767503) Oxygen content in Capillary blood by calculation

536

3022

1.23

4.82

2.4

2.6

16.3

15.7

2.42

256

1646

(3048689) Calprotectin [Mass/mass] in Stool

1312

10226

0.88

4.81

1.8

2.0

180.3

165.8

ug/g

0.58

959

7773

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

132

1349

0.67

4.81

1.1

1.3

275.8

259.1

pmol/l

0.27

1027

(3013115) Eosinophils [#/volume] in Blood

7842

56282

0.94

4.75

5.0

5.8

0.2

e9/l

0.44

6699

48138

(3007461) Platelets [#/volume] in Blood

16247

110278

1.09

4.67

29.7

27.2

236.8

239.0

e9/l

3.76

15613

106669

(3035941) MCH [Entitic mass]

16248

110287

1.09

4.66

29.5

27.1

30.4

0.63

15761

108129

(3032057) Clostridioides difficile [Presence] in Stool

324

1.71

4.66

1.5

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

16249

110296

1.09

4.65

29.7

27.2

4.3

4.4

e12/l

116.34

15544

106181

(3016502) Oxygen saturation in Arterial blood

2281

14369

1.11

4.64

4.7

6.6

95.0

95.3

1.00

2187

13807

(3024731) MCV [Entitic volume]

16248

110293

1.09

4.63

29.6

27.1

92.0

91.8

2.45

15766

108133

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.35

4.63

1.1

1.2

20.2

17.0

pmol/l

0.19

(3027801) Oxygen [Partial pressure] in Arterial blood

2537

16069

1.10

4.63

4.6

6.4

11.3

11.8

kpa

4.95

2390

15226

(3000963) Hemoglobin [Mass/volume] in Blood

16250

110308

1.09

4.63

29.9

27.4

128.7

131.9

g/l

130.77

15764

108161

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

142

2.09

4.61

3.3

3.0

36.7

41.0

umol/l

0.59

113

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

433

3691

0.80

4.60

1.1

1.6

1.2

u/ml

0.31

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2538

16082

1.10

4.59

4.6

6.4

5.0

5.1

kpa

2.56

2395

15244

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

410

1.62

4.59

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

233

1189

1.36

4.57

2.3

2.5

2.3

u/field

0.09

431

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

655

0.55

4.57

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

655

0.55

4.57

1.3

1.1

—

(3044889) 12 lead EKG panel

10832

76876

0.94

4.56

4.7

4.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

581

0.52

4.53

1.0

0.5

1.0

u/ml

0.84

239

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

652

0.55

4.50

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

651

0.55

4.48

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

466

0.47

4.43

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

466

0.47

4.43

1.0

0.2

1.2

u/ml

—

116

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

984

0.64

4.40

1.0

1.1

118.8

115.2

0.45

851

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

655

0.56

4.38

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2002

15139

0.90

4.37

4.4

5.1

34.7

33.7

3.08

1223

9702

(3000764) Benzodiazepines [Presence] in Urine

106

470

1.56

4.36

2.0

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

905

0.62

4.35

1.1

1.2

99.4

78.5

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

211

1954

0.74

4.34

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

296

0.35

4.34

1.2

1.3

—

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

7303

52426

0.94

4.33

5.4

6.1

24.1

25.5

19.79

6542

48043

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

116

1188

0.67

4.32

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

132

1318

0.69

4.30

1.2

1.3

—

nmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

651

0.56

4.29

1.3

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1895

11877

1.11

4.26

4.3

6.0

1.5

1.4

mmol/l

4.94

1806

11377

(3003888) Timothy IgE Ab [Units/volume] in Serum

596

0.54

4.26

1.0

0.3

2.7

u/ml

5.17

267

(3025130) Human papilloma virus identified in Specimen

578

0.54

4.26

1.8

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2825

20990

0.92

4.25

4.1

4.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

152

0.23

4.23

1.4

1.5

—

(3027008) Opiates [Presence] in Urine

106

475

1.54

4.18

2.0

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

144

688

1.45

4.17

1.7

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

223

2035

0.75

4.16

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

106

477

1.54

4.11

2.0

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

4042

29559

0.93

4.08

3.7

4.1

81.0

83.4

6.99

3909

28910

(46235355) HIV 1 and 2 tests - Meaningful Use set

1184

9185

0.88

4.07

1.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

787

0.61

4.05

1.0

—

(3042733) HLA Ab [Presence] in Serum

172

0.28

3.97

5.0

4.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

139

1352

0.71

3.94

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

105

2.17

3.92

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

939

0.65

3.89

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

391

1.57

3.86

1.1

72.7

477.5

ng/l

1.79

111

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

810

0.63

3.84

1.1

1.2

100.0

186.6

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

810

0.63

3.84

1.1

1.2

190.0

129.7

titre

0.32

145

(4306422)

1010

0.67

3.82

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

246

1303

1.31

3.82

1.7

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

170

0.28

3.82

1.1

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

766

0.62

3.81

1.0

1.2

94.9

92.2

0.36

702

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

384

0.47

3.81

1.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

1536

9580

1.11

3.80

5.3

4.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

634

3728

1.18

3.74

2.6

3.2

25.0

24.9

mmol/l

0.21

555

3273

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

118

1168

0.69

3.73

1.7

1.8

171.9

189.1

pmol/l

1.24

101

1067

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

113

1127

0.69

3.72

1.1

1.2

4.6

4.9

u/ml

0.05

381

(3028717) Thiamine [Mass/volume] in Blood

2.27

3.72

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

361

0.46

3.70

1.0

1.9

2.0

u/ml

—

147

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

333

2843

0.80

3.67

1.6

26.5

5.7

iu/ml

0.75

102

712

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

175

0.31

3.67

1.0

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

961

7500

0.88

3.66

5.7

7.7

24.4

mmol/l

0.07

860

6914

(3006184) Hemoglobin [Mass/volume] in Capillary blood

562

3278

1.19

3.66

2.1

2.3

128.0

126.1

g/l

1.04

432

2379

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

387

0.48

3.65

1.5

1.7

312195.2

38014.8

u/ml

—

(3051593) INR in Capillary blood by Coagulation assay

172

871

1.36

3.64

6.9

12.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

592

0.58

3.60

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

7781

55531

0.94

3.59

5.0

5.7

1.8

1.9

e9/l

1.98

6662

47618

(3023487) Leukocytes [#/volume] in Peritoneal fluid

458

0.53

3.59

1.5

1.9

522.0

3944.3

e6/l

1.03

314

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

129

1247

0.71

3.57

1.1

1.2

277.2

287.6

u/ml

0.15

755

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

401

0.50

3.54

1.2

1.4

53.5

129.0

pmol/l

0.57

140

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

926

0.67

3.52

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

184

0.34

3.52

1.3

1.4

—

(3024932) HLA-DR beta [Type]

184

0.34

3.52

1.2

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

184

0.34

3.52

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

185

0.34

3.51

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

185

0.34

3.51

1.3

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

250

1.68

3.50

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

999

0.68

3.50

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

278

2407

0.79

3.50

1.1

1.2

540.0

926.3

titre

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

408

0.51

3.48

1.5

1.8

1977.7

14363.1

e6/l

1.84

231

(3004616) Nuclear Ab [Presence] in Serum

137

1305

0.72

3.48

1.2

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

0.50

3.47

1.0

0.9

2.0

u/ml

0.62

161

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

254

2220

0.79

3.47

1.2

1.3

30.5

41.3

u/l

1.58

211

1916

(3003338) MCHC [Mass/volume]

11718

78973

1.06

3.43

27.7

24.9

330.2

330.9

g/l

12.01

11466

78238

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

609

0.60

3.42

2.1

2.3

—

(3022313) Gas panel - Capillary blood

1009

6182

1.13

3.41

3.4

4.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

158

0.31

3.41

1.1

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1669

12561

0.91

3.34

4.3

6.3

11.5

11.6

mmol/l

0.21

1510

11791

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

438

0.53

3.34

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

141

1327

0.73

3.34

1.3

11.8

11.9

u/l

0.03

106

1053

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

731

0.64

3.31

1.1

—

36.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

288

0.43

3.31

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

288

0.43

3.31

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

288

0.43

3.31

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

288

0.43

3.31

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

346

1.56

3.30

1.1

u/l

0.19

174

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

112

1092

0.71

3.30

1.1

1.2

5.6

4.3

u/ml

0.27

487

(3010370) Gastrin [Moles/volume] in Serum or Plasma

165

0.33

3.26

3.4

1.4

66.2

58.4

pmol/l

—

126

(4268621)

720

0.64

3.26

2.0

2.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.27

3.21

1.1

1.4

46.9

43.3

0.14

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

104

1020

0.70

3.18

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

330

0.48

3.17

1.2

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

706

0.64

3.16

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

152

0.32

3.14

1.1

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

153

0.32

3.13

1.1

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.31

3.12

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

169

1530

0.76

3.09

3.2

3.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

451

0.56

3.03

2.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

281

2381

0.81

2.97

1.1

109.1

138.8

titre

0.53

170

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

196

0.35

2.97

1.2

1.5

—

(3047189) Immunofixation for 24 hour Urine

711

0.66

2.95

1.2

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

1.91

2.91

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

282

0.46

2.91

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

214

0.39

2.90

2.6

2.5

726.2

1110.0

u/l

0.24

200

(3023520) Reticulocytes [#/volume] in Blood

2022

12957

1.08

2.89

2.1

2.5

65.3

67.9

e9/l

2.78

1583

9851

(3007147) Virus identified in Stool by Electron microscopy

6.04

2.88

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

11520

81095

0.95

2.88

24.7

22.6

14.0

0.84

11182

79208

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

146

0.33

2.86

1.4

1.5

—

(3024471) HLA-A [Type]

192

0.36

2.85

1.0

—

(42870588) Differential panel, method unspecified - Blood

5498

39418

0.95

2.84

4.6

5.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

406

0.56

2.83

7.1

3.7

49.7

57.0

u/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

250

0.44

2.82

7.6

8.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2596

19032

0.93

2.77

1.2

1.8

u/ml

0.02

602

4432

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

666

0.66

2.74

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

419

0.58

2.73

1.7

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

573

0.64

2.72

4.8

6.1

—

(40768806) Pleura Pathology biopsy report

223

1915

0.80

2.71

1.4

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1772

11327

1.09

2.70

1.7

2.1

0.2

g/l

1.00

1545

10457

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

754

0.68

2.69

3.9

5.0

15.6

105.9

u/ml

3.59

221

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

924

0.72

2.69

1.3

1.2

7.6

8.0

mmol/l

0.46

613

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

1.82

2.61

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

264

2215

0.82

2.58

1.6

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2018

12998

1.08

2.55

5.0

7.0

120.3

119.3

g/l

1.49

1954

12523

(40768446) Kidney Pathology biopsy report

322

0.53

2.54

1.1

1.5

—

(3021788) Differential panel - Synovial fluid

283

2353

0.83

2.53

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

189

1639

0.79

2.53

1.5

66.4

62.6

0.74

124

1024

(3027944) Amphetamines [Presence] in Urine

461

1.41

2.52

2.0

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

233

1973

0.81

2.51

1.6

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

442

0.61

2.48

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

217

0.44

2.46

1.8

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

508

4015

0.87

2.45

1.9

2.4

0.0

g/l

0.00

433

3667

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.03

2.44

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

212

1.60

2.40

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.93

2.39

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

305

2500

0.84

2.36

1.3

1.5

30.5

31.5

g/l

0.71

277

2221

(3011412) CD3 cells [#/volume] in Blood

917

0.74

2.35

2.3

2.0

1.1

e9/l

0.13

560

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

132

0.37

2.34

1.4

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

239

2001

0.82

2.33

1.3

1.5

79453.3

62475.9

e6/l

0.35

156

1179

(3020393) Adenovirus Ag [Presence] in Stool

104

1.86

2.32

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

230

0.48

2.31

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.26

2.31

1.4

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

730

0.71

2.31

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

730

0.71

2.31

1.3

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

239

0.49

2.30

1.5

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

407

0.61

2.30

2.2

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

705

5431

0.89

2.30

2.6

2.7

0.4

0.3

u/ml

0.32

412

3116

(3023323) Follitropin [Units/volume] in Serum or Plasma

889

0.74

2.29

1.6

1.4

37.7

33.1

iu/l

0.53

748

(3044007) Cell count panel - Peritoneal fluid

363

0.59

2.28

1.7

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

136

1209

0.77

2.27

1.6

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

776

0.72

2.27

1.5

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

200

0.45

2.26

5.2

7.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

355

2861

0.85

2.26

2.2

2.7

1.8

mg/l

0.48

293

2534

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

101

514

1.36

2.22

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

128

675

1.31

2.22

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

128

675

1.31

2.22

1.2

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

317

1.46

2.22

1.3

1.5

15.9

17.1

pmol/l

0.80

252

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

198

0.45

2.21

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

106

0.33

2.20

2.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

210

1178

1.23

2.20

1.7

1.6

30.2

25.2

u/ml

0.72

240

(3012441) Differential panel - Pleural fluid

227

1898

0.82

2.20

1.4

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

101

930

0.75

2.20

1.2

1.4

2.9

g/l

0.03

638

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

118

0.35

2.20

1.0

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

108

0.32

2.19

2.8

4.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

101

929

0.75

2.19

1.2

1.4

0.5

0.4

g/l

0.12

638

(3027135) IgG subclass 1 [Mass/volume] in Serum

101

929

0.75

2.19

1.2

1.4

7.4

7.2

g/l

0.21

635

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

262

1.50

2.18

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

157

1363

0.79

2.17

1.1

1.2

60.2

60.7

u/l

0.03

906

(3014576) Chloride [Moles/volume] in Serum or Plasma

2613

17083

1.06

2.17

4.8

6.3

104.5

104.3

mmol/l

1.46

2522

16691

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

161

1392

0.80

2.16

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

296

0.56

2.15

6.9

8.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

680

0.71

2.15

2.0

1.8

14.0

16.1

0.57

251

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

523

4082

0.88

2.14

1.9

2.4

0.0

g/l

0.06

435

3679

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

148

0.42

2.11

1.2

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

124

0.39

2.08

3.4

2.3

191.1

365.0

umol/l

—

115

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

215

1794

0.82

2.07

1.2

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

128

684

1.29

2.04

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

697

0.72

2.04

2.0

1.8

72.7

69.8

0.78

654

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

824

0.74

2.04

2.9

3.7

—

(3021901) Oxygen saturation in Capillary blood

465

2815

1.14

2.04

2.4

2.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

434

1.37

2.02

1.1

—

(40758558) Short blood count panel - Blood

3911

28059

0.95

2.01

5.7

6.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

445

3493

0.88

2.01

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

340

2015

1.17

2.00

1.1

5.4

12.9

u/ml

—

(3019977) pH of Arterial blood

151

827

1.26

1.99

2.1

2.4

7.4

0.08

342

(3028679) Herpes simplex virus Ab [Presence] in Serum

308

1.43

1.98

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.84

1.97

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

382

0.63

1.97

1.3

—

(40765096) Chromosome analysis panel by Banding

390

0.64

1.96

1.1

—

(3013512) EKG study

5609

37495

1.04

1.96

4.8

4.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

287

2321

0.85

1.96

3.0

3.4

2.0

1.4

1.01

206

1787

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

188

0.48

1.95

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

659

0.72

1.95

2.1

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

169

0.45

1.95

1.7

—

(4062490)

103

927

0.77

1.95

1.2

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

746

0.74

1.94

2.1

1.9

41.1

39.5

0.15

(3037556) Urate [Mass/volume] in Serum or Plasma

414

0.65

1.94

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.35

1.93

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

145

1250

0.80

1.93

1.2

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1166

8679

0.92

1.92

5.8

7.8

93.0

93.7

3.35

1157

8647

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

233

1913

0.84

1.91

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

232

1338

1.20

1.90

2.7

2.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

161

1368

0.81

1.89

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

5350

38054

0.96

1.88

2.4

2.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

565

4347

0.89

1.86

1.8

2.3

0.1

0.0

g/l

0.12

475

3927

(3028626) Oxygen [Partial pressure] in Capillary blood

532

3273

1.12

1.84

2.5

2.9

7.6

7.8

kpa

2.63

487

3033

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

507

0.69

1.84

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

173

1454

0.82

1.83

2.9

3.4

59.8

59.3

0.09

919

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

357

0.64

1.81

2.2

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

107

0.39

1.81

1.3

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

190

0.51

1.77

10.6

12.9

5.6

5.2

mmol/l

0.42

190

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

607

0.73

1.76

1.3

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

500

3858

0.89

1.76

1.6

1.7

—

(3045788) Cell count panel - Pleural fluid

203

1671

0.84

1.74

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

779

0.76

1.74

1.1

3.4

4.7

u/ml

0.32

176

(3029634) Reagin Ab [Titer] in Serum by VDRL

151

845

1.23

1.70

1.4

1.7

—

2.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

744

0.76

1.69

2.1

2.2

388.6

113.8

ug/min

0.37

183

(3003740) Influenza virus B Ag [Presence] in Specimen

538

0.72

1.69

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.95

1.68

1.5

1.6

25.4

22.6

mmol/l

1.49

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.87

1.67

1.0

—

(3012565) Volume of 24 hour Urine

593

0.73

1.67

1.8

2.2

1689.6

1814.8

0.37

493

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

212

0.55

1.65

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

780

0.77

1.65

1.2

104.7

93.6

u/l

0.30

676

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

205

1676

0.84

1.65

1.2

1.3

355.0

439.6

u/l

0.70

192

1587

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

282

2245

0.86

1.63

1.2

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

401

3115

0.89

1.61

1.6

18492.1

14649.9

e6/l

0.61

289

2204

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

518

3965

0.90

1.60

1.1

—

(3016750) Collection duration of Urine

815

0.78

1.60

1.9

2.1

517.1

498.2

min

1.27

569

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

100

876

0.79

1.59

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

200

1632

0.84

1.59

1.5

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

242

1943

0.86

1.57

1.2

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

1.57

0.0

1.7

—

1.9

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

1.57

0.0

1.0

—

0.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

144

1209

0.82

1.56

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.42

1.56

1.0

—

(44806420)

479

1.30

1.56

2.4

2.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

275

2184

0.87

1.55

1.3

1.5

2980.2

2279.5

e6/l

0.37

210

1575

(3036071) Salmonella sp Ab [Titer] in Serum

207

0.57

1.54

1.2

1.1

—

(3042936) Bacteria identified in Isolate by Culture

2433

17532

0.95

1.51

1.9

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

308

0.65

1.51

1.3

—

(3033799) Differential panel - Peritoneal fluid

397

0.69

1.49

1.6

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

142

0.49

1.48

1.8

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

298

0.65

1.48

3.5

2.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.75

1.45

1.6

2.5

0.8

mmol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

418

0.71

1.43

1.0

1.1

11.9

12.2

iu/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

537

0.74

1.43

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

122

1029

0.82

1.41

1.7

1.9

3.0

4.0

ug/l

1.30

107

890

(3017509) Phencyclidine [Presence] in Urine

2.54

1.41

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

148

0.51

1.40

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

613

0.76

1.39

1.3

1.5

4.6

3.6

0.27

136

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

760

0.79

1.39

1.2

37.7

27.5

u/l

0.64

648

(3034426) Prothrombin time (PT)

251

0.63

1.38

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

643

0.77

1.38

2.3

2.0

665.0

562.2

e6/l

0.55

282

(36660697) Celiac disease serology panel - Serum

943

6970

0.93

1.38

1.2

—

(4015189)

430

0.72

1.37

1.6

2.3

—

(3035933) Granulocytes/100 leukocytes in Blood

137

0.50

1.36

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

602

0.77

1.35

2.2

2.0

417.0

517.2

e6/l

1.32

511

(3022948) Iron [Moles/volume] in Serum or Plasma

3189

21235

1.04

1.34

2.2

2.6

11.2

11.9

umol/l

5.83

2762

19473

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

175

1.46

1.34

3.5

2.7

0.5

u/field

0.00

175

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.85

1.31

1.5

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

238

0.64

1.29

1.2

2.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

232

1834

0.87

1.28

1.2

1.4

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.42

1.28

1.0

1.4

—

27521.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15752

107800

1.04

1.27

23.5

22.1

85.4

85.2

umol/l

0.15

15745

107743

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

270

0.66

1.26

1.0

1.1

86.3

93.9

0.58

193

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

121

1.54

1.26

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

242

1.37

1.24

1.1

1711.4

1694.6

miu/ml

0.03

242

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.86

1.24

1.0

—

(3020491) Glucose [Moles/volume] in Blood

144

834

1.19

1.24

1.9

2.2

7.6

7.2

mmol/l

0.80

103

563

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

578

0.77

1.23

1.6

1.5

5.2

6.6

u/l

2.33

467

(3044927) Protein electrophoresis panel - Urine

272

1655

1.14

1.23

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

156

911

1.18

1.22

1.3

1.2

1.4

nmol/l

2.76

142

819

(3002331) Protein [Mass/volume] in Peritoneal fluid

292

0.68

1.21

1.4

1.3

24.5

47.4

g/l

0.63

238

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

249

1949

0.88

1.21

1.8

2.2

33.1

32.6

1.05

244

1933

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

363

0.72

1.19

2.4

2.0

18.7

44.9

u/l

2.19

340

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

1.18

0.0

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

241

0.66

1.18

1.1

1.3

109.8

115.2

0.44

207

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

241

0.66

1.18

1.2

1.1

78.0

81.7

—

125

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

150

1216

0.85

1.18

1.4

1.5

20.2

27.3

2.27

752

(3026692) Albumin [Mass/volume] in Peritoneal fluid

322

0.71

1.17

1.2

1.4

13.8

15.0

g/l

0.30

250

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.65

1.17

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

147

0.56

1.16

1.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

294

2271

0.89

1.16

1.3

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

377

0.73

1.16

1.1

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

167

1339

0.86

1.15

1.2

1.3

20.6

12.2

u/l

1.49

147

1231

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

189

0.62

1.14

1.8

4.3

39.7

42.4

u/l

0.18

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

239

0.66

1.14

1.2

97.6

79.4

—

127

(3000093) Morphology [Interpretation] in Blood Narrative

172

1375

0.86

1.14

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

203

1603

0.87

1.14

1.3

1.4

6.1

6.4

mmol/l

0.91

182

1488

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

137

0.55

1.13

1.0

3.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

303

0.71

1.12

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

139

1128

0.85

1.12

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

139

1128

0.85

1.12

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

139

1128

0.85

1.12

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

790

0.82

1.11

1.5

1.6

4.1

7.3

u/l

1.66

372

(3001186) Copper [Moles/volume] in Serum or Plasma

148

1.45

1.11

1.2

1.1

16.4

16.5

umol/l

0.00

133

(3034860) Kappa light chains.free [Mass/volume] in Serum

704

5206

0.93

1.10

2.2

3.2

55.6

79.2

mg/l

1.13

542

4241

(3027923) C peptide [Moles/volume] in Serum or Plasma

537

1.22

1.08

1.3

1.1

1.2

nmol/l

0.07

408

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.48

1.07

1.5

4.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.76

1.07

1.3

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

193

0.64

1.05

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

704

5195

0.93

1.05

2.2

3.2

49.0

mg/l

0.00

545

4231

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

298

0.72

1.04

2.8

2.2

—

(3015183) Erythrocyte sedimentation rate

217

0.67

1.04

1.2

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

478

1.23

1.03

1.9

1.8

13.7

14.7

nmol/l

0.59

437

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

158

0.61

1.02

1.1

—

(3025577) Chromium [Mass/volume] in Blood

122

991

0.85

1.02

1.7

2.0

1.8

2.3

ug/l

1.74

821

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

120

976

0.85

1.02

1.1

0.8

2.3

iu/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

306

1.29

1.02

2.8

2.5

7.5

7.8

mmol/l

0.32

200

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

675

0.82

1.01

1.1

27.8

30.4

u/l

0.17

481

(4024509)

217

1324

1.13

1.00

1.5

1.7

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.99

0.0

1.1

—

1921.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

277

2123

0.90

0.99

2.6

3.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

673

0.82

0.99

1.1

78.8

91.4

u/l

0.93

496

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

285

2180

0.90

0.99

1.6

2.8

4.8

iu/l

6.49

629

(4146454)

204

1589

0.88

0.97

2.5

2.7

—

(44813793)

524

0.80

0.93

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

102

1.49

0.93

16.4

10.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

12703

86813

1.03

0.93

22.6

20.2

36.6

38.0

24.60

6554

51377

(3016650) Hepatitis A virus Ab [Presence] in Serum

162

1276

0.87

0.93

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

160

1.38

0.93

1.1

1.3

2928.5

181.0

ng/l

0.50

109

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

244

1.30

0.92

2.7

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.47

0.91

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

290

0.74

0.91

1.9

2.2

3.2

3.5

ug/l

0.19

112

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.53

0.90

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.52

0.90

1.1

—

mmol/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1575

10437

1.04

0.89

1.9

2.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.72

0.89

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

143

0.63

0.88

1.0

1.1

3.7

20.1

iu/ml

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

527

0.81

0.87

1.3

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

527

0.81

0.87

1.3

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

804

0.85

0.87

1.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

314

1.25

0.86

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

263

2002

0.90

0.86

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.66

0.85

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

563

0.82

0.85

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

630

0.83

0.84

1.2

1.1

2.6

4.5

iu/ml

—

(3027035) Albumin [Mass/time] in 24 hour Urine

116

0.59

0.84

1.4

1.3

—

743.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

801

0.85

0.84

1.3

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

770

5611

0.94

0.83

1.9

2.3

10.2

10.3

g/l

0.16

570

4612

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

162

986

1.13

0.82

1.3

257.8

451.2

titre

0.83

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

115

0.60

0.82

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

257

1952

0.91

0.82

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1020

7371

0.95

0.81

6.2

8.6

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.81

0.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.81

0.0

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.81

0.0

6.0

—

(3024928) Oxygen saturation in Venous blood

427

2733

1.08

0.81

2.3

2.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.72

0.81

1.8

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

295

1860

1.10

0.80

2.1

2.2

30.5

28.2

mg/l

0.23

454

(3036048) Francisella tularensis Ab [Titer] in Serum

204

0.71

0.79

1.0

1.2

—

1344.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6727

45699

1.02

0.79

4.8

5.9

5.0

4.5

ug/l

0.24

5710

40281

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

527

0.82

0.78

2.4

2.6

42.2

36.7

0.81

191

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1481

10603

0.96

0.78

2.3

2.4

35.6

47.9

u/l

0.90

1209

9017

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

557

0.83

0.78

1.2

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.78

0.0

1.1

—

165.8

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.78

0.0

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

282

0.76

0.78

1.5

1.6

90.6

114.0

ug/l

0.69

237

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.77

0.78

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

258

0.75

0.77

1.1

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

692

5043

0.94

0.77

2.2

3.2

1.8

5.2

ratio

1.41

355

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15557

107873

0.98

0.76

10.3

11.9

22.3

24.2

u/l

11.51

14607

102921

(3042517) Benzodiazepines panel - Urine

2.16

0.76

1.6

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

761

5523

0.95

0.74

1.9

2.3

3.1

g/l

0.72

518

4230

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

689

5013

0.95

0.73

1.9

2.5

1.2

1.1

g/l

0.19

517

4202

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1012

7287

0.96

0.72

1.4

1.6

g/l

0.50

799

6215

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

265

1993

0.92

0.72

1.2

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1208

8664

0.96

0.72

5.6

7.7

0.7

4.63

1194

8600

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

159

1227

0.89

0.71

1.1

51.8

407.6

iu/ml

0.90

219

(3012494) Peanut IgE Ab [Units/volume] in Serum

143

0.67

0.71

1.0

1.1

0.1

0.6

u/ml

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.68

0.70

1.0

—

35.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

268

0.77

0.68

1.3

1.1

0.6

0.7

umol/24h

0.04

121

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

533

0.84

0.68

1.3

1.8

—

(46235168) Fasting glucose [Moles/volume] in Blood

110

1.38

0.68

12.3

1.8

8.6

7.5

mmol/l

0.95

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

394

2908

0.93

0.68

1.3

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

125

0.66

0.67

1.2

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

359

0.81

0.67

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

825

5953

0.95

0.66

1.9

2.3

3.9

3.8

g/l

0.25

511

4158

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1214

8686

0.96

0.66

5.5

7.6

1.5

1.3

6.20

1200

8622

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

934

0.89

0.64

1.2

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

155

960

1.11

0.64

1.3

49.0

65.1

titre

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

677

0.87

0.64

1.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

677

0.87

0.64

1.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

677

0.87

0.64

1.2

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

241

0.77

0.63

2.0

1.6

9.7

ug/l

0.01

241

(3044941) Cell count panel - Synovial fluid

268

1999

0.92

0.63

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

828

5964

0.96

0.62

1.9

2.3

—

(3045414) Leukocytes [Presence] in Urine

772

5088

1.05

0.62

2.1

2.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.62

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

106

0.65

0.62

1.6

1.5

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

119

921

0.89

0.60

1.1

1.2

143.5

209.3

miu/ml

0.74

252

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

830

5969

0.96

0.59

1.9

2.3

7.5

g/l

0.11

527

4322

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

121

0.68

0.59

1.0

1.2

1.7

umol/24h

0.02

121

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

496

3610

0.95

0.58

1.7

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

389

0.83

0.58

1.1

ratio

1.01

120

(3048879) Bone marrow aspiration report

478

0.85

0.57

1.2

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

676

0.88

0.56

2.9

3.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

365

0.83

0.56

1.1

1.2

—

(4212803)

159

0.74

0.56

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.55

0.56

1.3

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

115

708

1.12

0.55

2.0

16.7

28.7

umol/l

0.93

(3013293) Extractable nuclear Ab [Presence] in Serum

143

0.72

0.55

1.8

1.5

—

(3004775) Volume in Urine collected for unspecified duration

153

1161

0.91

0.55

2.0

2.2

651.9

659.0

0.07

739

(3000991) Gas panel - Venous blood

1612

11429

0.97

0.55

5.0

7.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.52

0.54

1.1

1.0

208.4

169.7

pmol/l

—

(4133840)

181

0.76

0.53

1.4

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.67

0.53

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

641

4619

0.96

0.52

1.8

2.3

36.7

36.9

g/l

0.37

471

3868

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

279

0.82

0.51

1.2

1.1

275.3

272.0

pmol/l

0.02

192

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

405

2642

1.06

0.51

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.35

0.51

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.35

0.51

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.35

0.51

1.1

1.2

—

(3014891) Appearance of Pleural fluid

266

1.19

0.51

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

352

2574

0.94

0.51

1.5

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

589

1.12

0.50

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

427

0.86

0.50

1.3

34.5

32.8

u/l

0.13

352

(3022493) Free Hemoglobin [Mass/volume] in Plasma

530

0.87

0.50

1.1

3.1

61.7

73.8

mg/l

0.81

363

(3011648) Oxygen content in Venous blood

113

865

0.90

0.50

1.3

1.7

9.7

10.8

1.78

113

865

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.32

0.49

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

675

0.89

0.49

1.2

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

580

0.88

0.49

1.4

3.0

2.4

0.26

482

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

514

0.87

0.49

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

237

1524

1.07

0.48

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

666

0.89

0.47

1.3

1.4

60.4

66.7

0.87

542

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

498

0.87

0.47

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

149

1.25

0.47

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.70

0.47

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

118

737

1.10

0.47

2.4

2.0

2.5

2.4

u/field

0.01

488

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

146

0.76

0.47

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.43

0.46

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

535

3851

0.96

0.45

2.2

3.4

—

(3017732) Neutrophils [#/volume] in Blood

1054

7054

1.03

0.44

3.4

3.2

4.3

4.2

e9/l

0.59

666

4857

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

157

1.23

0.43

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

178

1139

1.08

0.43

1.3

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

166

1235

0.93

0.42

1.6

1.9

1.4

0.7

g/24h

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.42

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.38

0.41

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

753

0.91

0.41

1.5

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4591

32046

0.98

0.41

2.7

3.2

34.9

36.6

u/l

0.50

4226

29983

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

108

679

1.10

0.40

1.9

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

239

0.84

0.38

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

141

1.22

0.38

2.8

6.0

—

(3001729) Color of Synovial fluid

116

1.25

0.38

1.5

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

116

1.25

0.38

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

283

0.85

0.38

1.4

1.5

11.1

9.8

0.08

144

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

260

0.85

0.37

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.73

0.37

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

472

0.89

0.36

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

472

0.89

0.36

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

399

0.88

0.36

1.6

1.5

0.2

nmol/l

0.91

290

(3037121) Protein [Mass/volume] in Urine

681

4547

1.03

0.36

2.4

2.9

0.3

g/l

0.42

235

1891

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

193

1.18

0.36

1.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

892

6324

0.97

0.36

2.5

2.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.43

0.36

1.5

1.4

503.6

412.0

nmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

372

2680

0.96

0.36

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

316

1.14

0.35

1.4

1.5

0.4

ug/l

0.26

183

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

128

817

1.08

0.35

1.1

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

165

1215

0.94

0.35

1.3

1.4

13.2

13.5

u/l

0.16

155

1165

(3025468) Yersinia sp identified in Specimen by Organism specific culture

242

1581

1.06

0.35

1.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

221

0.84

0.34

1.7

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

105

786

0.92

0.34

1.1

1.2

—

(44806118)

169

1242

0.94

0.34

1.2

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.33

0.34

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

206

1504

0.94

0.34

3.5

3.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2952

20631

0.98

0.33

2.3

2.9

0.8

mmol/l

0.02

2604

18987

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

250

1638

1.05

0.33

1.3

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

175

0.83

0.32

2.6

2.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

366

0.89

0.32

1.7

1.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

278

0.87

0.32

1.9

1.8

10.5

12.0

0.17

246

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

241

1580

1.05

0.32

1.3

1.4

—

(3024263) Appearance of Synovial fluid

100

636

1.08

0.31

1.4

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

495

3532

0.97

0.31

1.1

206.5

210.9

titre

0.01

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

314

0.88

0.31

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

248

0.86

0.31

1.3

1.2

40.5

78.9

mu/l

1.60

177

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.33

0.31

1.0

1.1

—

(44790048)

170

1242

0.94

0.30

1.2

1.3

—

(44790047)

170

1242

0.94

0.30

1.2

1.3

—

(44790049)

170

1242

0.94

0.30

1.2

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

241

1584

1.05

0.30

1.3

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.73

0.29

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.72

0.29

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.72

0.29

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

202

0.85

0.29

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

506

0.91

0.28

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

211

1528

0.95

0.28

3.6

3.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.75

0.28

1.7

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

161

1173

0.95

0.27

1.2

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

273

1962

0.96

0.27

1.3

1.4

0.8

nmol/l

0.27

209

1604

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

898

6059

1.02

0.26

2.3

2.5

45.7

30.4

au/ml

0.63

170

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

156

0.84

0.26

1.7

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

423

1.09

0.26

5.6

5.1

62.3

72.7

1.94

330

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2687

18750

0.99

0.26

2.3

2.6

20.6

21.1

1.23

2051

15821

(3024869) Neuronal Ab [Presence] in Serum

252

1.12

0.26

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.27

0.26

1.1

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

298

1.11

0.26

2.0

2.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

101

650

1.07

0.26

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.73

0.24

8.5

8.4

—

(40762365) Oxygen content in Arterial blood by calculation

264

0.89

0.24

3.1

2.8

15.4

14.6

ml/dl

0.83

246

(3025315) Body weight

0.80

0.24

7.1

5.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

154

0.85

0.24

1.1

1.2

7.0

6.5

mmol/l

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1841

12866

0.99

0.23

2.1

2.6

9.4

9.8

umol/l

0.25

1527

11217

(3018851) Theophylline [Moles/volume] in Serum or Plasma

156

1.15

0.23

1.3

1.7

43.0

46.9

umol/l

0.38

156

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

578

0.93

0.23

1.0

294.9

290.6

mg/l

0.19

506

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

146

0.85

0.23

2.0

3.8

9.8

ug/l

0.62

(3041918) Cholesterol [Moles/volume] in Pleural fluid

313

0.90

0.23

1.0

1.2

1.4

1.5

mmol/l

0.22

194

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

514

1.07

0.22

1.8

1.7

2188.1

1216.3

u/l

0.23

192

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

204

1467

0.96

0.22

1.3

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.23

0.22

1.2

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.22

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.22

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.1

—

27.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.22

0.0

1.4

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.22

0.0

6.8

—

8.9

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.22

0.0

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.22

0.0

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

455

0.92

0.21

1.3

1.5

17.7

11.4

umol/l

0.30

315

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.19

0.21

1.0

—

(3019174) dRVVT (LA screen)

0.78

0.21

1.0

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

469

0.93

0.21

1.2

39.3

40.3

g/l

0.27

231

(3013166) Neutrophils/100 leukocytes in Synovial fluid

402

1.08

0.21

1.3

1.4

75.7

59.9

4.32

345

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.21

0.0

6.8

—

6.5

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.7

—

15.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

368

0.92

0.20

1.3

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

471

3330

0.97

0.20

2.0

2.3

123.2

106.7

ug/min

0.29

234

1886

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

166

0.87

0.20

1.0

1.5

—

46.8

—

(44786800) Granulocytes/100 leukocytes in Body fluid

244

1.10

0.20

1.3

1.4

22.2

21.3

0.06

192

(3035611) Eosinophils/100 leukocytes in Synovial fluid

100

1.17

0.19

1.5

1.8

1.3

0.8

0.27

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

530

0.94

0.19

1.3

1001.7

189.1

ug/l

0.86

285

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

465

1.07

0.19

1.7

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

316

0.92

0.19

1.1

1.2

—

(3004451) EKG impression Narrative

116

761

1.05

0.19

1.2

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

101

1.16

0.18

1.8

—

(3006462) Nitrate [Presence] in Urine

620

0.95

0.18

4.3

4.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

167

1.12

0.17

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.73

0.17

1.4

1.1

173.4

299.6

nmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

239

1598

1.03

0.17

1.3

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.84

0.17

1.1

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

241

1612

1.03

0.17

1.3

1.4

—

(3020650) Glucose [Presence] in Urine

207

1.10

0.17

2.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

247

1.09

0.16

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.15

0.16

2.0

2.7

—

(3046861) Legionella sp Ag [Presence] in Urine

1.18

0.16

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

284

0.92

0.15

5.4

6.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

124

822

1.04

0.14

3.4

2.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

174

1239

0.97

0.14

1.2

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3385

23479

0.99

0.13

1.6

1.7

1.6

1.5

mg/l

0.39

2617

18438

(3044009) aPTT.lupus sensitive (LA screen)

0.85

0.13

1.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.83

0.13

3.1

3.5

—

(3037756) Immunofixation for Serum or Plasma

487

3414

0.98

0.12

1.3

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

316

0.94

0.12

1.3

30.3

32.0

0.10

205

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1086

7565

0.99

0.12

2.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

173

1226

0.97

0.12

1.2

—

(3000012) Reticulocyte production index

132

882

1.03

0.11

1.7

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

266

1796

1.02

0.11

5.9

6.1

12.7

12.4

mg/l

0.55

233

1618

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

433

3034

0.98

0.11

1.3

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2893

19844

1.01

0.11

2.2

2.6

2.2

2.3

g/l

3.76

2513

18201

(3014051) Protein [Presence] in Urine by Test strip

402

2729

1.02

0.10

2.6

2.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

482

0.96

0.10

2.2

2.7

—

(3000060) B lymphocytes [#/volume] in Blood

165

0.92

0.10

2.2

1.8

2804.6

1226.4

e6/l

0.24

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.15

0.10

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

166

1172

0.98

0.09

2.3

1.8

366.5

301.1

mu/l

1.01

153

1077

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

228

0.94

0.09

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.11

0.09

1.1

10.2

9.4

u/l

0.12

(3024316) Viscosity of Plasma

1.15

0.09

2.1

1.8

1.6

1.8

mpas

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

346

0.96

0.08

1.1

—

(3017569) Oxygen content in Arterial blood

108

725

1.03

0.08

2.0

2.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.07

0.08

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

681

0.97

0.08

1.1

1.2

11.6

12.1

mmol/l

0.21

213

(3017704) Immunofixation for Urine

122

862

0.98

0.08

1.2

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.83

0.08

1.2

1.0

—

(3000285) Sodium [Moles/volume] in Blood

202

1.06

0.07

1.5

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

106

0.91

0.07

2.1

1.8

76.7

61.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

113

0.92

0.07

1.3

1.0

—

(44806071)

1.11

0.07

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1821

12500

1.01

0.07

2.0

2.6

65.4

65.9

g/l

2.03

1502

11186

(3017315) Amylase [Enzymatic activity/volume] in Urine

581

0.97

0.06

1.2

180.3

318.9

u/l

1.60

533

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

785

5451

0.99

0.06

1.3

43.6

61.3

au/ml

1.40

228

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

217

0.95

0.05

1.3

1.4

76.1

74.7

0.09

184

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2520

17432

1.00

0.05

3.8

5.3

1.0

mmol/l

1.81

2217

15940

(3028433) Virus identified in Specimen by Culture

377

0.97

0.05

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

302

2102

0.99

0.04

2.9

3.2

4.7

4.4

e9/l

0.91

302

2096

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1129

7754

1.00

0.04

4.4

6.1

24.8

mmol/l

0.02

1111

7669

(3045716) Anion gap in Serum or Plasma

643

1.02

0.04

1.8

2.2

9.6

8.9

mmol/l

0.70

477

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

431

0.98

0.04

1.3

1.4

18.6

21.0

0.30

364

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.08

0.04

1.2

1.1

1.0

u/field

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

240

1.03

0.04

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

562

1.02

0.03

1.2

1.3

4.0

3.3

mmol/l

1.06

514

(3002621) Streptococcal DNAse B [Units/volume] in Serum

103

0.94

0.03

1.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.93

0.03

2.2

1.8

6.0

15.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

175

1219

0.99

0.03

1.2

1.4

155581.5

174781.5

e6/l

0.11

110

836

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.08

0.03

2.1

1.2

1.4

1.0

u/field

—

(3006576) Bicarbonate [Moles/volume] in Blood

481

1.02

0.03

3.8

6.6

24.6

25.0

mmol/l

0.32

435

(3051651) Icteric interference index of Serum or Plasma

115

803

0.99

0.03

3.6

4.0

—

(3035880) pH of Pleural fluid

143

976

1.01

0.03

1.1

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

220

0.97

0.02

1.0

1.3

37.3

364.3

u/l

0.86

152

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

105

1.05

0.02

1.1

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

525

3610

1.00

0.01

1.4

271.0

259.2

ug/g

0.68

284

2247

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

260

1785

1.00

0.01

1.3

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

385

0.99

0.01

1.5

1.7

6.8

5.2

nmol/l

0.19

333

(4211845)

664

1.01

0.00

4.2

4.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.95

0.00

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

584

0.99

0.00

1.0

1.1

2.9

9.1

nmol/l

1.34

131

(3052851) Hemolysis interference index of Serum or Plasma

594

4091

1.00

0.00

3.7

—

(3003129) Base excess in Capillary blood by calculation

375

1.01

0.00

1.4

1.9

1.8

0.6

mmol/l

2.02

356

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.94

0.00

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

127

1.03

0.00

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

163

1.02

0.00

1.5

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

183

1.02

0.00

1.1

1.3

74.6

113.0

ug/l

1.05

114

(3042010) Triglyceride [Moles/volume] in Pleural fluid

238

0.99

0.00

1.0

1.3

0.6

1.5

mmol/l

1.40

150

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

259

1.01

0.00

1.3

1.5

103.9

129.0

ng/l

1.00

259

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

167

0.99

0.00

1.0

1.2

16.1

17.6

u/l

0.23

118

(3025549) Creatine [Moles/time] in 24 hour Urine

117

1.00

0.00

1.3

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.98

0.00

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

795

5482

1.00

0.00

2.7

3.2

4.3

pmol/l

0.27

650

4730

(3002619) Bacteria identified in Specimen by Culture

245

1.01

0.00

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

320

0.99

0.00

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

269

1.00

0.00

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

133

0.99

0.00

1.4

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

169

1167

1.00

0.00

2.6

3.1

49.2

38.8

mg/l

0.28

124

852

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.96

0.00

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.05

0.00

1.1

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.05

0.00

1.0

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5286

36450

1.00

0.00

4.4

5.0

21.7

22.5

3.44

2683

20238

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.91

0.00

1.0

1.1

—

0.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.01

0.00

1.0

1.2

21.5

31.7

nmol/l

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.6

—

34.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.86

0.00

1.0

1.2

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

135.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.4

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

22.9

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

50.6

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.4

—

(3049242) von Willebrand panel - Platelet poor plasma

1.01

0.00

1.2

2.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.88

0.00

1.0

4.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.93

0.00

1.2

1.4

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.6

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_DEMENTIA_INCLAVO and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_DEMENTIA_INCLAVO	2.557 [2.36, 2.77]	< 0.001
Birth year	0.983 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 125629 out of 199294 females with F5_DEMENTIA_INCLAVO died.

Males

Parameter	HR [95% CI]	p-value
F5_DEMENTIA_INCLAVO	2.722 [2.44, 3.04]	< 0.001
Birth year	0.98 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 78758 out of 122214 males with F5_DEMENTIA_INCLAVO died.

Mortality risk

Mortality risk for people of age

years, who have F5_DEMENTIA_INCLAVO.

N-year risk	Females	Males
1	0.106%	0.363%
5	0.708%	1.942%
10	1.677%	4.878%
15	3.286%	8.802%
20	5.623%	14.153%

Relationships between endpoints

↥

Index endpoint: F5_DEMENTIA_INCLAVO – Dementia, including avohilmo

GWS hits: 40

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dementia, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints